Raymond1109 personal page - To The Moon

Raymond1109

Raymond1109

No personal profile

16Follow

7Followers

0Topic

0Badge

2021-04-29

$Histogenics(OCGN)$FDA kindly approve histo for emergency use ?????

2021-05-04

$Histogenics(OCGN)$FDA & EUA soon ???????

2021-05-04

$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$Phase 3 trail gotta succeed soon! Comeon! ???????

2021-05-04

$Microvision(MVIS)$Where’s the Reddit push to $100? Hahahah

2021-05-04

$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$Silent for way too long~ something should be cooking soon!!

2021-06-21

Note to self~

A Stock Market Crash Is Coming: 5 High-Conviction Stocks to Buy Hand Over Fist When It Happens

2021-06-14

Naked gogogo

7 Penny Stocks To Watch Before They Pop Due to Reddit Users

2021-04-30

$Histogenics(OCGN)$Time to fly high, soar away!! ??

2021-04-27

$Histogenics(OCGN)$Awaiting the FDA approval~

2021-05-13

$iPower Inc.(IPW)$??????

2021-05-08

$Microvision(MVIS)$Hodl only, only next week can see abit more of greens~

2021-07-05

Time to soar!

Ocugen says Indian partner's vaccine 93.4% effective against severe COVID-19

2021-05-27

May it be approved soon then~ the discussion has been way too long.. already no joy upon the news, only the actual graph can excite

BRIEF-Ocugen Says On Track To Submit EUA Application To U.S. FDA For Its COVID-19 Vaccine Candidate, Covaxin

2021-05-14

$Naked Brand(NAKD)$18-20% surge can’t be all we got right…. ☝?☝?

2021-05-14

$Naked Brand(NAKD)$+8% to +10% now, what are the chances post market +50%? Hmm ?

2021-05-10

$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$Today financial report, hope all is good ?? it has been WAYYYYY too long since there is any much movement from this!

2021-04-29

$Histogenics(OCGN)$It’s about time right?

2021-04-29

$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$Really need to hold till clinical trial phase 3 to see it ? again

2021-04-27

$Histogenics(OCGN)$Time to soar ?? 14-15 tomorrow will be good ????

2021-07-05

Great ariticle, would you like to share it?

@koonkoon:$Histogenics(OCGn)good news

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3582000739695630","uuid":"3582000739695630","gmtCreate":1618938827256,"gmtModify":1618972651960,"name":"Raymond1109","pinyin":"raymond1109","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":16,"tweetSize":48,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"60.80%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"60.36%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":154946922,"gmtCreate":1625473168066,"gmtModify":1703742360407,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Time to soar!","listText":"Time to soar!","text":"Time to soar!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/154946922","repostId":"2148801599","repostType":2,"repost":{"id":"2148801599","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625576711,"share":"https://ttm.financial/m/news/2148801599?lang=&edition=fundamental","pubTime":"2021-07-06 21:05","market":"us","language":"en","title":"Ocugen says Indian partner's vaccine 93.4% effective against severe COVID-19","url":"https://stock-news.laohu8.com/highlight/detail?id=2148801599","media":"Reuters","summary":"July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's Indian partner, Bharat Biotech, ha","content":"<p>July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's Indian partner, Bharat Biotech, has been found to be 93.4% effective against severe cases of COVID-19 in a late-stage trial, the U.S. drug developer said on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen says Indian partner's vaccine 93.4% effective against severe COVID-19</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen says Indian partner's vaccine 93.4% effective against severe COVID-19\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-06 21:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's Indian partner, Bharat Biotech, has been found to be 93.4% effective against severe cases of COVID-19 in a late-stage trial, the U.S. drug developer said on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2148801599","content_text":"July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's Indian partner, Bharat Biotech, has been found to be 93.4% effective against severe cases of COVID-19 in a late-stage trial, the U.S. drug developer said on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":154941707,"gmtCreate":1625473069409,"gmtModify":1703742357615,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/154941707","repostId":"155231719","repostType":1,"repost":{"id":155231719,"gmtCreate":1625438214331,"gmtModify":1703741555205,"author":{"id":"3564546889826365","authorId":"3564546889826365","name":"koonkoon","avatar":"https://static.tigerbbs.com/5dcc75085d1205dc8567a05395bac661","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3564546889826365","authorIdStr":"3564546889826365"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCG</a>n)good news","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCG</a>n)good news","text":"$Histogenics(OCGn)good news","images":[{"img":"https://static.tigerbbs.com/289870db1bfd26ce1e7e3a3fe788f25c","width":"1080","height":"975"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/155231719","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":152237822,"gmtCreate":1625295203366,"gmtModify":1703740160147,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Yeah boiii~","listText":"Yeah boiii~","text":"Yeah boiii~","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/152237822","repostId":"2148801599","repostType":2,"repost":{"id":"2148801599","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625576711,"share":"https://ttm.financial/m/news/2148801599?lang=&edition=fundamental","pubTime":"2021-07-06 21:05","market":"us","language":"en","title":"Ocugen says Indian partner's vaccine 93.4% effective against severe COVID-19","url":"https://stock-news.laohu8.com/highlight/detail?id=2148801599","media":"Reuters","summary":"July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's Indian partner, Bharat Biotech, ha","content":"<p>July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's Indian partner, Bharat Biotech, has been found to be 93.4% effective against severe cases of COVID-19 in a late-stage trial, the U.S. drug developer said on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen says Indian partner's vaccine 93.4% effective against severe COVID-19</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen says Indian partner's vaccine 93.4% effective against severe COVID-19\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-06 21:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's Indian partner, Bharat Biotech, has been found to be 93.4% effective against severe cases of COVID-19 in a late-stage trial, the U.S. drug developer said on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2148801599","content_text":"July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's Indian partner, Bharat Biotech, has been found to be 93.4% effective against severe cases of COVID-19 in a late-stage trial, the U.S. drug developer said on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":481,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126884085,"gmtCreate":1624551241047,"gmtModify":1703840261038,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Gogogo ~","listText":"Gogogo ~","text":"Gogogo ~","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126884085","repostId":"126046481","repostType":1,"repost":{"id":126046481,"gmtCreate":1624539809643,"gmtModify":1703839745435,"author":{"id":"3578811676095048","authorId":"3578811676095048","name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578811676095048","authorIdStr":"3578811676095048"},"themes":[],"htmlText":"Check this You Tube from this Investors --&nbsp;interesting read. Average Shorties 16%-20%, average Long is 80%-84%. It’s quite stable. Strongly recommended to hold till $10. Cheers!&nbsp;https://youtu.be/6ZLYVb8HmlA","listText":"Check this You Tube from this Investors --&nbsp;interesting read. Average Shorties 16%-20%, average Long is 80%-84%. It’s quite stable. Strongly recommended to hold till $10. Cheers!&nbsp;https://youtu.be/6ZLYVb8HmlA","text":"Check this You Tube from this Investors -- interesting read. Average Shorties 16%-20%, average Long is 80%-84%. It’s quite stable. Strongly recommended to hold till $10. Cheers! https://youtu.be/6ZLYVb8HmlA","images":[{"img":"https://static.tigerbbs.com/a882c72deb9cc00e00761e8aec2b7832","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126046481","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":464,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128289730,"gmtCreate":1624518478120,"gmtModify":1703839113417,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Sounds like OCGN linked ? hahaha","listText":"Sounds like OCGN linked ? hahaha","text":"Sounds like OCGN linked ? hahaha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128289730","repostId":"2145198180","repostType":2,"repost":{"id":"2145198180","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624492031,"share":"https://ttm.financial/m/news/2145198180?lang=&edition=fundamental","pubTime":"2021-06-24 07:47","market":"us","language":"en","title":"UPDATE 1-Brazil sets single-day record for coronavirus cases","url":"https://stock-news.laohu8.com/highlight/detail?id=2145198180","media":"Reuters","summary":"(Adds context on outbreak, details of Senate investigation)   RIO DE JANEIRO, June 23 (Reuters) - Br","content":"<html><body><p>(Adds context on outbreak, details of Senate investigation)</p><p>   RIO DE JANEIRO, June 23 (Reuters) - Brazil registered a single-day record of 115,228 new confirmed coronavirus cases in the past 24 hours, the Health Ministry said on Wednesday, as its outbreak shows new signs of accelerating despite long-delayed vaccination efforts finally gaining steam.</p><p>   Brazil has recorded the world's highest COVID-19 death toll outside the United States, with more than half a million lives lost, according to the ministry's official tally. </p><p>   But while the situation in the United States and most wealthy nations improves thanks to higher vaccination rates, Brazil and many neighbors in South America this month have seen their biggest outbreaks yet.  </p><p>   Brazil's seven-day average for new coronavirus cases and deaths is now the highest in the world, having surpassed India last week, according to data compiled </p><p>by Reuters.</p><p>   Brazil marked the milestone of 500,000 COVID-19 deaths over the weekend with nationwide protests against the government's handling of the pandemic. </p><p>   The country has been slow to roll out vaccines with only 12% of Brazilians fully immunized, according to Health Ministry data. Efforts have accelerated recently, with certain states such as Sao Paulo predicting shots for all adults by September.</p><p>   The government of President Jair Bolsonaro is under scrutiny for delays and alleged misconduct in obtaining vaccines, having failed to respond to early offers from Pfizer    last year.</p><p>   The government instead struck a deal for more a expensive vaccine made by India's Bharat Biotech.</p><p>   A Senate committee is probing allegations related to Bharat amid a wider investigation of the government's response.  </p><p>   A Brazilian Health Ministry official told prosecutors he faced internal pressure from an aide to then-Health Minister Eduardo Pazuello to buy the Bharat shot.  </p><p>   In a press briefing on Wednesday, Bolsonaro's Secretary of the Presidency Onyx Lorenzoni said there had been no influence peddling in the Bharat deal and the vaccines were not overpriced.</p><p>    The Health Ministry did not respond to request for comment about the allegations.</p><p>   On Wednesday, the committee also called representatives of <a href=\"https://laohu8.com/S/FB\">Facebook</a>   , Google    and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>    to testify before the committee as it weighs possible crimes related to misinformation online about COVID-19.  </p><p> (Reporting by Pedro Fonseca Additional reporting by Jake Spring Editing by Brad Haynes and Lincoln Feast.)</p><p>((jake.spring@thomsonreuters.com; +55 61 99653-2429; Reuters Messaging: jake.spring.thomsonreuters.com@reuters.net / Twitter: ))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 1-Brazil sets single-day record for coronavirus cases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 1-Brazil sets single-day record for coronavirus cases\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-24 07:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds context on outbreak, details of Senate investigation)</p><p>   RIO DE JANEIRO, June 23 (Reuters) - Brazil registered a single-day record of 115,228 new confirmed coronavirus cases in the past 24 hours, the Health Ministry said on Wednesday, as its outbreak shows new signs of accelerating despite long-delayed vaccination efforts finally gaining steam.</p><p>   Brazil has recorded the world's highest COVID-19 death toll outside the United States, with more than half a million lives lost, according to the ministry's official tally. </p><p>   But while the situation in the United States and most wealthy nations improves thanks to higher vaccination rates, Brazil and many neighbors in South America this month have seen their biggest outbreaks yet.  </p><p>   Brazil's seven-day average for new coronavirus cases and deaths is now the highest in the world, having surpassed India last week, according to data compiled </p><p>by Reuters.</p><p>   Brazil marked the milestone of 500,000 COVID-19 deaths over the weekend with nationwide protests against the government's handling of the pandemic. </p><p>   The country has been slow to roll out vaccines with only 12% of Brazilians fully immunized, according to Health Ministry data. Efforts have accelerated recently, with certain states such as Sao Paulo predicting shots for all adults by September.</p><p>   The government of President Jair Bolsonaro is under scrutiny for delays and alleged misconduct in obtaining vaccines, having failed to respond to early offers from Pfizer    last year.</p><p>   The government instead struck a deal for more a expensive vaccine made by India's Bharat Biotech.</p><p>   A Senate committee is probing allegations related to Bharat amid a wider investigation of the government's response.  </p><p>   A Brazilian Health Ministry official told prosecutors he faced internal pressure from an aide to then-Health Minister Eduardo Pazuello to buy the Bharat shot.  </p><p>   In a press briefing on Wednesday, Bolsonaro's Secretary of the Presidency Onyx Lorenzoni said there had been no influence peddling in the Bharat deal and the vaccines were not overpriced.</p><p>    The Health Ministry did not respond to request for comment about the allegations.</p><p>   On Wednesday, the committee also called representatives of <a href=\"https://laohu8.com/S/FB\">Facebook</a>   , Google    and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>    to testify before the committee as it weighs possible crimes related to misinformation online about COVID-19.  </p><p> (Reporting by Pedro Fonseca Additional reporting by Jake Spring Editing by Brad Haynes and Lincoln Feast.)</p><p>((jake.spring@thomsonreuters.com; +55 61 99653-2429; Reuters Messaging: jake.spring.thomsonreuters.com@reuters.net / Twitter: ))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","QNETCN":"纳斯达克中美互联网老虎指数","03086":"华夏纳指","TWTR":"Twitter","GOOGL":"谷歌A","09086":"华夏纳指-U"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145198180","content_text":"(Adds context on outbreak, details of Senate investigation)   RIO DE JANEIRO, June 23 (Reuters) - Brazil registered a single-day record of 115,228 new confirmed coronavirus cases in the past 24 hours, the Health Ministry said on Wednesday, as its outbreak shows new signs of accelerating despite long-delayed vaccination efforts finally gaining steam.   Brazil has recorded the world's highest COVID-19 death toll outside the United States, with more than half a million lives lost, according to the ministry's official tally.    But while the situation in the United States and most wealthy nations improves thanks to higher vaccination rates, Brazil and many neighbors in South America this month have seen their biggest outbreaks yet.     Brazil's seven-day average for new coronavirus cases and deaths is now the highest in the world, having surpassed India last week, according to data compiled by Reuters.   Brazil marked the milestone of 500,000 COVID-19 deaths over the weekend with nationwide protests against the government's handling of the pandemic.    The country has been slow to roll out vaccines with only 12% of Brazilians fully immunized, according to Health Ministry data. Efforts have accelerated recently, with certain states such as Sao Paulo predicting shots for all adults by September.   The government of President Jair Bolsonaro is under scrutiny for delays and alleged misconduct in obtaining vaccines, having failed to respond to early offers from Pfizer    last year.   The government instead struck a deal for more a expensive vaccine made by India's Bharat Biotech.   A Senate committee is probing allegations related to Bharat amid a wider investigation of the government's response.     A Brazilian Health Ministry official told prosecutors he faced internal pressure from an aide to then-Health Minister Eduardo Pazuello to buy the Bharat shot.     In a press briefing on Wednesday, Bolsonaro's Secretary of the Presidency Onyx Lorenzoni said there had been no influence peddling in the Bharat deal and the vaccines were not overpriced.    The Health Ministry did not respond to request for comment about the allegations.   On Wednesday, the committee also called representatives of Facebook   , Google    and Twitter    to testify before the committee as it weighs possible crimes related to misinformation online about COVID-19.   (Reporting by Pedro Fonseca Additional reporting by Jake Spring Editing by Brad Haynes and Lincoln Feast.)((jake.spring@thomsonreuters.com; +55 61 99653-2429; Reuters Messaging: jake.spring.thomsonreuters.com@reuters.net / Twitter: ))","news_type":1},"isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129222000,"gmtCreate":1624374578800,"gmtModify":1703834908053,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Interesting~","listText":"Interesting~","text":"Interesting~","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129222000","repostId":"129132467","repostType":1,"repost":{"id":129132467,"gmtCreate":1624364306159,"gmtModify":1703834423584,"author":{"id":"3578811676095048","authorId":"3578811676095048","name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578811676095048","authorIdStr":"3578811676095048"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Check this out guys!&nbsp;","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Check this out guys!&nbsp;","text":"$Histogenics(OCGN)$Check this out guys!","images":[{"img":"https://static.tigerbbs.com/cccdea4ad529ce5300dc28629a8de1d1","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129132467","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129221773,"gmtCreate":1624374502792,"gmtModify":1703834905106,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Come on come on!","listText":"Come on come on!","text":"Come on come on!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129221773","repostId":"129962987","repostType":1,"repost":{"id":129962987,"gmtCreate":1624352277249,"gmtModify":1703834178471,"author":{"id":"3578811676095048","authorId":"3578811676095048","name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578811676095048","authorIdStr":"3578811676095048"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Check&nbsp;this out. Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today:&nbsp;https://www.ndtv.com/india-news/covaxin-phase-3-trial-data-bharat-biotech-submits-phase-3-trial-data-expert-committee-to-meet-today-2469383","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Check&nbsp;this out. Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today:&nbsp;https://www.ndtv.com/india-news/covaxin-phase-3-trial-data-bharat-biotech-submits-phase-3-trial-data-expert-committee-to-meet-today-2469383","text":"$Histogenics(OCGN)$Check this out. Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today: https://www.ndtv.com/india-news/covaxin-phase-3-trial-data-bharat-biotech-submits-phase-3-trial-data-expert-committee-to-meet-today-2469383","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129962987","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120366509,"gmtCreate":1624301200701,"gmtModify":1703832917219,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"????????","listText":"????????","text":"????????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120366509","repostId":"167542426","repostType":1,"repost":{"id":167542426,"gmtCreate":1624279535665,"gmtModify":1703832258199,"author":{"id":"3578811676095048","authorId":"3578811676095048","name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578811676095048","authorIdStr":"3578811676095048"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Phase 3 Clinically trials results submitted over the weekend. Cheers Everyone!&nbsp;","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Phase 3 Clinically trials results submitted over the weekend. Cheers Everyone!&nbsp;","text":"$Histogenics(OCGN)$Phase 3 Clinically trials results submitted over the weekend. Cheers Everyone!","images":[{"img":"https://static.tigerbbs.com/2f9c323292adba33d21f8925c3d4b921","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/167542426","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":485,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164587366,"gmtCreate":1624230013555,"gmtModify":1703830813306,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Note to self~","listText":"Note to self~","text":"Note to self~","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164587366","repostId":"1126454279","repostType":2,"repost":{"id":"1126454279","kind":"news","pubTimestamp":1624151746,"share":"https://ttm.financial/m/news/1126454279?lang=&edition=fundamental","pubTime":"2021-06-20 09:15","market":"us","language":"en","title":"A Stock Market Crash Is Coming: 5 High-Conviction Stocks to Buy Hand Over Fist When It Happens","url":"https://stock-news.laohu8.com/highlight/detail?id=1126454279","media":"fool","summary":"It might be the last thing you want to hear, but it's the truth:A stock market crash is inevitable.\n","content":"<p>It might be the last thing you want to hear, but it's the truth:A stock market crash is inevitable.</p>\n<p>Since the March 23, 2020 bottom, investors have enjoyed a historically strong bounce-back rally -- the widely followed<b>S&amp;P 500</b>(SNPINDEX:^GSPC)has gained an impressive 90%. But both history and valuation metrics unequivocally suggest that a big drop is upcoming for the stock market.</p>\n<p><b>History is pretty clear that trouble lies ahead</b></p>\n<p>For example, there have beenone or two double-digit percentage declineswithin the three years following a bottom in each of the previous eight bear markets prior to the coronavirus crash (i.e., dating back to 1960). Although bull markets tend to last years, rebounds from a bear market are never this smooth. We're nearly 15 months past the March 2020 bear-market bottom in the S&amp;P 500 and have yet to see anything close to a double-digit correction.</p>\n<p>To add to this point, data from market analytics firm Yardeni Research shows that there have been 38 double-digit declines in the S&amp;P 500 over the past 71 years. That's a crash or correction, on average,every 1.87 years. Though the market doesn't adhere to averages, it does give a general sense of when to expect these hiccups.</p>\n<p>On a valuation basis, the S&amp;P 500's Shiller price-to-earnings (P/E) ratio is a waving red flag. The S&amp;P 500's Shiller P/E -- a measure of inflation-adjusted earnings over the previous 10 years -- almost hit 38 earlier this week. That more than doubles its 151-year average, and it's the highest level in nearly two decades. The previous four times the Shiller P/E surpassed and held above 30 during a bull market rally, the indexsubsequently declined by a minimum of 20%.</p>\n<p>Make no mistake about it -- a stock market crash is coming.</p>\n<p>Every crash or correction is an opportunity for patient investors to make money</p>\n<p>However, a crash is no reason to duck and cover. While history may signal trouble ahead, it also tells us that each and every double-digit decline has been a buying opportunity. Eventually, every big drop in the major indexes is erased by a bull-market rally. When the next crash does occur, the following five high-conviction stocks can be confidently bought hand over fist.</p>\n<p><b>CrowdStrike Holdings</b></p>\n<p>Cybersecurity is projected to beone of the safest double-digit growth trendsthis decade. No matter the size of the business or the state of the U.S./global economy, protecting enterprise and consumer data is paramount. This means cloud-based cybersecurity stock<b>CrowdStrike Holdings</b>(NASDAQ:CRWD)can thrive in any environment.</p>\n<p>CrowdStrike's successderives from its cloud-native Falcon security platform. Because it's built in the cloud and relies on artificial intelligence, it's growing smarter at identifying and responding to threats all the time. It's currently overseeing 6 trillion events on a weekly basis, and it's far more cost-effective at protecting data than on-premise solutions.</p>\n<p>We can also look to the company's income statements to see clear-cut evidence that businesses favor CrowdStrike's cybersecurity platform. It's been retaining 98% of its clients, has seen existing clients spend 23% to 47% more on a year-over-year basis for the past 12 quarters, and recently reported that 64% of its customers have purchased at least four cloud module subscriptions. Scaling with its customers is CrowdStrike's ticket to big-time cash flow expansion.</p>\n<p><b>Facebook</b></p>\n<p>Brand-name businesses can make patient investors a fortune, and social media giant<b>Facebook</b>(NASDAQ:FB)is the perfect example.</p>\n<p>When the curtain closed on March, Facebook tallied 2.85 billion monthly active users (MAU) visiting its namesake site and an additional 600 million unique MAUs visiting WhatsApp or Instagram, which it also owns. All told, this equates to44% of the global populationinteracting with its owned sites each month. There's simply no social media platform businesses can go to get their message to a broader (or potentially targeted) audience, which is why Facebook ad-pricing power is so strong.</p>\n<p>But here's the kicker: Facebookhasn't even put the pedal to the metal. Although it's on track to generate more than $100 billion in advertising revenue in 2021, nearly all of these ad sales are coming from its namesake site and Instagram. WhatsApp and Facebook Messenger, which are two of the six most-visited social sites in the world, aren't being meaningfully monetized as of yet. Further, the company's Oculus virtual reality devices are still in the early stage of their growth. Suffice it to say, Facebook offers ample upside as its other operating segments are monetized and mature.</p>\n<p><b>NextEra Energy</b></p>\n<p>Another high-conviction stock to buy hand over fist the next time a crash or steep correction strikes is electric utility stock<b>NextEra Energy</b>(NYSE:NEE).</p>\n<p>Did I put you to sleep when I said \"electric utility stock?\" Electric utilities are traditionally known for their market-topping dividend yields and persistently low growth rates. But this doesn't describe NextEra Energy. NextEra has aggressively invested in renewable energy projects and is leading the country in solar and wind capacity. As a result of these investments, its electric generation costs have declined and its compound annual growth ratehas consistently been in the high single digitsfor more than a decade. It also doesn't hurt that NextEra is front-running any potential green-energy legislation that might come out of Washington.</p>\n<p>In addition to growth rates that are well above the sector average, NextEra still benefits from the predictability of energy demand. For instance, its regulated utilities (i.e., those not powered by renewable energy) require approval from state utility commissions before price hikes can be passed along to households. This might sound like an inconvenience, but it's actually great news. It means NextEra won't be exposed to potentially volatile wholesale pricing.</p>\n<p><b>Visa</b></p>\n<p>When the next stock market crash arrives, payment processing kingpin<b>Visa</b>(NYSE:V)is a winning company to confidently buy hand over fist. It's also another brand-name company thatcan still make its shareholders a fortune.</p>\n<p>Buying into the Visa growth story is a simple numbers game. Visa grows its revenue and profits when consumers and businesses are spending more. This happens when the U.S. and global economy are expanding. Although contractions and recessions are an inevitable part of the economic cycle, they tend to be short-lived. Meanwhile, periods of economic expansion are almost always measured in years. Buying into Visa during these short-lived crashes or corrections should allow long-term investors to be handsomely rewarded by this numbers game.</p>\n<p>The other interesting thing about Visa is thatit's shunned becoming a lender. You'd think that Visa could generate big bucks from interest income and fees by lending during these long-lived periods of expansion. But lending would also expose Visa to the credit delinquencies that arise during recessions. Operating solely as a payment processor means not having to set aside cash to cover delinquencies. It's why Visa rebounds so much faster than most financial stocks following a recession.</p>\n<p><b>Amazon</b></p>\n<p>Lastly (andwho couldn't see this coming?), investors should take any discount they can get during a crash on e-commerce behemoth<b>Amazon</b>(NASDAQ:AMZN).</p>\n<p>Amazon's online marketplace has proved virtually unstoppable for well over a decade. An April 2021 report from eMarketer pegged the company's share of U.S. online sales at 40.4%. That more than quintuples its next-closest competitor and effectively solidifies Amazon as the go-to source for online shopping in the U.S.</p>\n<p>What about those pesky low retail margins, you ask? Amazon has signed up more than 200 million people globally to a Prime membership. The fees collected from Prime members help to offset some of the company's retail-based margin weakness. Prime members are extremely loyal to the Amazon ecosystem and spend far more than non-members, too.</p>\n<p>But it's Amazon's cloud infrastructure segmentthat's the superstar. Amazon Web Services (AWS) brings in around one-eighth of the company's total sales but accounts for well over half its operating income. Since cloud margins are superior to retail and advertising margins, AWS is the company's key to explosive cash flow growth this decade.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Stock Market Crash Is Coming: 5 High-Conviction Stocks to Buy Hand Over Fist When It Happens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Stock Market Crash Is Coming: 5 High-Conviction Stocks to Buy Hand Over Fist When It Happens\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-20 09:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/19/stock-market-crash-coming-5-high-conviction-stocks/><strong>fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It might be the last thing you want to hear, but it's the truth:A stock market crash is inevitable.\nSince the March 23, 2020 bottom, investors have enjoyed a historically strong bounce-back rally -- ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/19/stock-market-crash-coming-5-high-conviction-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NEP":"Nextera Energy Partners","V":"Visa","CRWD":"CrowdStrike Holdings, Inc.","AMZN":"亚马逊"},"source_url":"https://www.fool.com/investing/2021/06/19/stock-market-crash-coming-5-high-conviction-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126454279","content_text":"It might be the last thing you want to hear, but it's the truth:A stock market crash is inevitable.\nSince the March 23, 2020 bottom, investors have enjoyed a historically strong bounce-back rally -- the widely followedS&P 500(SNPINDEX:^GSPC)has gained an impressive 90%. But both history and valuation metrics unequivocally suggest that a big drop is upcoming for the stock market.\nHistory is pretty clear that trouble lies ahead\nFor example, there have beenone or two double-digit percentage declineswithin the three years following a bottom in each of the previous eight bear markets prior to the coronavirus crash (i.e., dating back to 1960). Although bull markets tend to last years, rebounds from a bear market are never this smooth. We're nearly 15 months past the March 2020 bear-market bottom in the S&P 500 and have yet to see anything close to a double-digit correction.\nTo add to this point, data from market analytics firm Yardeni Research shows that there have been 38 double-digit declines in the S&P 500 over the past 71 years. That's a crash or correction, on average,every 1.87 years. Though the market doesn't adhere to averages, it does give a general sense of when to expect these hiccups.\nOn a valuation basis, the S&P 500's Shiller price-to-earnings (P/E) ratio is a waving red flag. The S&P 500's Shiller P/E -- a measure of inflation-adjusted earnings over the previous 10 years -- almost hit 38 earlier this week. That more than doubles its 151-year average, and it's the highest level in nearly two decades. The previous four times the Shiller P/E surpassed and held above 30 during a bull market rally, the indexsubsequently declined by a minimum of 20%.\nMake no mistake about it -- a stock market crash is coming.\nEvery crash or correction is an opportunity for patient investors to make money\nHowever, a crash is no reason to duck and cover. While history may signal trouble ahead, it also tells us that each and every double-digit decline has been a buying opportunity. Eventually, every big drop in the major indexes is erased by a bull-market rally. When the next crash does occur, the following five high-conviction stocks can be confidently bought hand over fist.\nCrowdStrike Holdings\nCybersecurity is projected to beone of the safest double-digit growth trendsthis decade. No matter the size of the business or the state of the U.S./global economy, protecting enterprise and consumer data is paramount. This means cloud-based cybersecurity stockCrowdStrike Holdings(NASDAQ:CRWD)can thrive in any environment.\nCrowdStrike's successderives from its cloud-native Falcon security platform. Because it's built in the cloud and relies on artificial intelligence, it's growing smarter at identifying and responding to threats all the time. It's currently overseeing 6 trillion events on a weekly basis, and it's far more cost-effective at protecting data than on-premise solutions.\nWe can also look to the company's income statements to see clear-cut evidence that businesses favor CrowdStrike's cybersecurity platform. It's been retaining 98% of its clients, has seen existing clients spend 23% to 47% more on a year-over-year basis for the past 12 quarters, and recently reported that 64% of its customers have purchased at least four cloud module subscriptions. Scaling with its customers is CrowdStrike's ticket to big-time cash flow expansion.\nFacebook\nBrand-name businesses can make patient investors a fortune, and social media giantFacebook(NASDAQ:FB)is the perfect example.\nWhen the curtain closed on March, Facebook tallied 2.85 billion monthly active users (MAU) visiting its namesake site and an additional 600 million unique MAUs visiting WhatsApp or Instagram, which it also owns. All told, this equates to44% of the global populationinteracting with its owned sites each month. There's simply no social media platform businesses can go to get their message to a broader (or potentially targeted) audience, which is why Facebook ad-pricing power is so strong.\nBut here's the kicker: Facebookhasn't even put the pedal to the metal. Although it's on track to generate more than $100 billion in advertising revenue in 2021, nearly all of these ad sales are coming from its namesake site and Instagram. WhatsApp and Facebook Messenger, which are two of the six most-visited social sites in the world, aren't being meaningfully monetized as of yet. Further, the company's Oculus virtual reality devices are still in the early stage of their growth. Suffice it to say, Facebook offers ample upside as its other operating segments are monetized and mature.\nNextEra Energy\nAnother high-conviction stock to buy hand over fist the next time a crash or steep correction strikes is electric utility stockNextEra Energy(NYSE:NEE).\nDid I put you to sleep when I said \"electric utility stock?\" Electric utilities are traditionally known for their market-topping dividend yields and persistently low growth rates. But this doesn't describe NextEra Energy. NextEra has aggressively invested in renewable energy projects and is leading the country in solar and wind capacity. As a result of these investments, its electric generation costs have declined and its compound annual growth ratehas consistently been in the high single digitsfor more than a decade. It also doesn't hurt that NextEra is front-running any potential green-energy legislation that might come out of Washington.\nIn addition to growth rates that are well above the sector average, NextEra still benefits from the predictability of energy demand. For instance, its regulated utilities (i.e., those not powered by renewable energy) require approval from state utility commissions before price hikes can be passed along to households. This might sound like an inconvenience, but it's actually great news. It means NextEra won't be exposed to potentially volatile wholesale pricing.\nVisa\nWhen the next stock market crash arrives, payment processing kingpinVisa(NYSE:V)is a winning company to confidently buy hand over fist. It's also another brand-name company thatcan still make its shareholders a fortune.\nBuying into the Visa growth story is a simple numbers game. Visa grows its revenue and profits when consumers and businesses are spending more. This happens when the U.S. and global economy are expanding. Although contractions and recessions are an inevitable part of the economic cycle, they tend to be short-lived. Meanwhile, periods of economic expansion are almost always measured in years. Buying into Visa during these short-lived crashes or corrections should allow long-term investors to be handsomely rewarded by this numbers game.\nThe other interesting thing about Visa is thatit's shunned becoming a lender. You'd think that Visa could generate big bucks from interest income and fees by lending during these long-lived periods of expansion. But lending would also expose Visa to the credit delinquencies that arise during recessions. Operating solely as a payment processor means not having to set aside cash to cover delinquencies. It's why Visa rebounds so much faster than most financial stocks following a recession.\nAmazon\nLastly (andwho couldn't see this coming?), investors should take any discount they can get during a crash on e-commerce behemothAmazon(NASDAQ:AMZN).\nAmazon's online marketplace has proved virtually unstoppable for well over a decade. An April 2021 report from eMarketer pegged the company's share of U.S. online sales at 40.4%. That more than quintuples its next-closest competitor and effectively solidifies Amazon as the go-to source for online shopping in the U.S.\nWhat about those pesky low retail margins, you ask? Amazon has signed up more than 200 million people globally to a Prime membership. The fees collected from Prime members help to offset some of the company's retail-based margin weakness. Prime members are extremely loyal to the Amazon ecosystem and spend far more than non-members, too.\nBut it's Amazon's cloud infrastructure segmentthat's the superstar. Amazon Web Services (AWS) brings in around one-eighth of the company's total sales but accounts for well over half its operating income. Since cloud margins are superior to retail and advertising margins, AWS is the company's key to explosive cash flow growth this decade.","news_type":1},"isVote":1,"tweetType":1,"viewCount":384,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187176592,"gmtCreate":1623748052316,"gmtModify":1704210300731,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"IPO are always like a gamble HAHAHA&nbsp;","listText":"IPO are always like a gamble HAHAHA&nbsp;","text":"IPO are always like a gamble HAHAHA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187176592","repostId":"1175897310","repostType":4,"repost":{"id":"1175897310","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1623725513,"share":"https://ttm.financial/m/news/1175897310?lang=&edition=fundamental","pubTime":"2021-06-15 10:51","market":"us","language":"en","title":"IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=1175897310","media":"Benzinga","summary":"This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is ","content":"<p>This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week.</p>\n<p><b>AMTD Digital:</b>Asian digital solutions platform&nbsp;<b>AMTD Digital</b>(NYSE:HKD)&nbsp;offers&nbsp;risk solutions and digital insurance technology for partners. The company had revenue of $21.6 million in fiscal 2020 and $18.8 million through the first nine months of the current fiscal year. The company plans to sell 16 million ADSs at a price point of $6.80 to $8.20.</p>\n<p><b>Molecular Partners:</b>Clinical stage biotechnology company&nbsp;<b>Molecular Partners</b>(NASDAQ:MOLN) isfocusedon using its pioneering DARPin product in categories including infectious diseases, oncology and ophthalmology. The company partnered with&nbsp;<b>Novartis</b>(NYSE:NVS) in 2020,<b>Amgen Inc</b>(NASDAQ:AMGN) in 2018 and&nbsp;<b>AbbVie Inc</b>(NYSE:ABBV) in 2011. Novartis owns 6% of the company. Molecular Partners plans to sell 3 million ADS.</p>\n<p><b>WalkMe:</b>With a mission to change the way humans interact with technology,<b>WalkMe</b>(NASDAQ:WKME)offerssolutions for organizations. The company has many well-known companies as customers including Nestle and Veolia, two large European companies listed as case studies in the filing.</p>\n<p>WalkMe had revenue of $148 million in 2020 and revenue of $42.7 million in the first quarter of 2021. The company’s revenue was up 34% year-over-year in the last twelve months. The company has 368 customers that represent $100,000 or more in annual revenue and 22 customers that represent $1 million or more in annual revenue. WalkMe plans on selling 9.25 million shares at a price point of $29 to $32.</p>\n<p><b>Convey Holding:</b>Health care company&nbsp;<b>Convey Holding</b>(NYSE:CNVY)partnerswith eight of the 10 largest Medicare Advantage companies in the U.S. The company had 2.5 million Medicare Advantage and 1.6 million Prescription Drug Plan members in 2020. Revenue in 2020 for the company was $282.9 million. First-quarter 2021 revenue was $82.6 million for the company. Convey Holding plans to sell 13.3 million shares at a price point of $14 to $16.</p>\n<p><b>Angel Oak Mortgage:</b>Real estate finance company&nbsp;<b>Angel Oak Mortgage</b>(NYSE: AOMR)&nbsp;acquiresand invests in first&nbsp;lien non-QM Loans and other mortgage assets in the U.S. The company had assets of $534.9 million at the end of the first quarter of 2021. The company has elected to be taxed as a REIT. Angel Oak Mortgage is seeking to sell 8.1 million shares at a price point of $20 to $21.</p>\n<p><b>Lyell Immunopharma:</b>Seeking to disrupt the T-cell reprogramming market,<b>Lyell ImmunoPharma</b>(NASDAQ:LYEL)intendsto have four INDs submitted by the end of 2022. The company partnered with<b>GlaxoSmithKline</b>(NYSE:GSK) in 2019 in a deal good for up to $400 million in additional milestones after a $45-million upfront payment.</p>\n<p>GlaxoSmithKline owns 14% of Lyell and&nbsp;<b>Bristol-MyersSquibb</b>(NYSE:BMY) owned Celgene owns 5% of the company. Lyell is planning to sell 25 million shares at a price point of $16 to $18.</p>\n<p><b>Verve Therapeutics:</b>Genetic medicine company<b>Verve Therapeutics</b>(NASDAQ: VERV) isfocusedon cardiovascular disease. The company plans to sell 11.8 million shares at a price point of $16 to $18.</p>\n<p><b>Atai Life Sciences:</b>Backedby&nbsp;<b>Palantir Technologies</b>(NYSE:PLTR) and&nbsp;<b>Paypal Holdings</b>(NASDAQ:PYPL) founder Peter Thiel,<b>Atai Life Sciences</b>(NASDAQ:ATAI) could be one of the high profile IPOs of the week.</p>\n<p>The company isdevelopingtreatment options for mental health disorders. The company has 10 programs in its pipeline and six enabling technologies. The company is planning on selling 14.3 million shares at a price point of $13 to $15.</p>\n<p><b>AiHui Shou International:</b>Pre-owned consumer electronics reseller&nbsp;<b>AiHuiShou International</b>(NYSE: RERE)seeksto give a second life to all idle goods.</p>\n<p>The company’s three business lines — AHS Recycle, PJUT Marketplace and PaiPai Marketplace — help the company as the market leader in China with a market share of 6.6%. The company had revenue of $741.5 million in 2020 and $231.1 million in the first quarter of 2021, up 119% year-over-year.<b>JD.com</b>(NASDAQ:JD) will own 32.3% of the company after the IPO. The company plans on selling 16.2 million ADSs at a price point of $13 to $15.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-06-15 10:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week.</p>\n<p><b>AMTD Digital:</b>Asian digital solutions platform&nbsp;<b>AMTD Digital</b>(NYSE:HKD)&nbsp;offers&nbsp;risk solutions and digital insurance technology for partners. The company had revenue of $21.6 million in fiscal 2020 and $18.8 million through the first nine months of the current fiscal year. The company plans to sell 16 million ADSs at a price point of $6.80 to $8.20.</p>\n<p><b>Molecular Partners:</b>Clinical stage biotechnology company&nbsp;<b>Molecular Partners</b>(NASDAQ:MOLN) isfocusedon using its pioneering DARPin product in categories including infectious diseases, oncology and ophthalmology. The company partnered with&nbsp;<b>Novartis</b>(NYSE:NVS) in 2020,<b>Amgen Inc</b>(NASDAQ:AMGN) in 2018 and&nbsp;<b>AbbVie Inc</b>(NYSE:ABBV) in 2011. Novartis owns 6% of the company. Molecular Partners plans to sell 3 million ADS.</p>\n<p><b>WalkMe:</b>With a mission to change the way humans interact with technology,<b>WalkMe</b>(NASDAQ:WKME)offerssolutions for organizations. The company has many well-known companies as customers including Nestle and Veolia, two large European companies listed as case studies in the filing.</p>\n<p>WalkMe had revenue of $148 million in 2020 and revenue of $42.7 million in the first quarter of 2021. The company’s revenue was up 34% year-over-year in the last twelve months. The company has 368 customers that represent $100,000 or more in annual revenue and 22 customers that represent $1 million or more in annual revenue. WalkMe plans on selling 9.25 million shares at a price point of $29 to $32.</p>\n<p><b>Convey Holding:</b>Health care company&nbsp;<b>Convey Holding</b>(NYSE:CNVY)partnerswith eight of the 10 largest Medicare Advantage companies in the U.S. The company had 2.5 million Medicare Advantage and 1.6 million Prescription Drug Plan members in 2020. Revenue in 2020 for the company was $282.9 million. First-quarter 2021 revenue was $82.6 million for the company. Convey Holding plans to sell 13.3 million shares at a price point of $14 to $16.</p>\n<p><b>Angel Oak Mortgage:</b>Real estate finance company&nbsp;<b>Angel Oak Mortgage</b>(NYSE: AOMR)&nbsp;acquiresand invests in first&nbsp;lien non-QM Loans and other mortgage assets in the U.S. The company had assets of $534.9 million at the end of the first quarter of 2021. The company has elected to be taxed as a REIT. Angel Oak Mortgage is seeking to sell 8.1 million shares at a price point of $20 to $21.</p>\n<p><b>Lyell Immunopharma:</b>Seeking to disrupt the T-cell reprogramming market,<b>Lyell ImmunoPharma</b>(NASDAQ:LYEL)intendsto have four INDs submitted by the end of 2022. The company partnered with<b>GlaxoSmithKline</b>(NYSE:GSK) in 2019 in a deal good for up to $400 million in additional milestones after a $45-million upfront payment.</p>\n<p>GlaxoSmithKline owns 14% of Lyell and&nbsp;<b>Bristol-MyersSquibb</b>(NYSE:BMY) owned Celgene owns 5% of the company. Lyell is planning to sell 25 million shares at a price point of $16 to $18.</p>\n<p><b>Verve Therapeutics:</b>Genetic medicine company<b>Verve Therapeutics</b>(NASDAQ: VERV) isfocusedon cardiovascular disease. The company plans to sell 11.8 million shares at a price point of $16 to $18.</p>\n<p><b>Atai Life Sciences:</b>Backedby&nbsp;<b>Palantir Technologies</b>(NYSE:PLTR) and&nbsp;<b>Paypal Holdings</b>(NASDAQ:PYPL) founder Peter Thiel,<b>Atai Life Sciences</b>(NASDAQ:ATAI) could be one of the high profile IPOs of the week.</p>\n<p>The company isdevelopingtreatment options for mental health disorders. The company has 10 programs in its pipeline and six enabling technologies. The company is planning on selling 14.3 million shares at a price point of $13 to $15.</p>\n<p><b>AiHui Shou International:</b>Pre-owned consumer electronics reseller&nbsp;<b>AiHuiShou International</b>(NYSE: RERE)seeksto give a second life to all idle goods.</p>\n<p>The company’s three business lines — AHS Recycle, PJUT Marketplace and PaiPai Marketplace — help the company as the market leader in China with a market share of 6.6%. The company had revenue of $741.5 million in 2020 and $231.1 million in the first quarter of 2021, up 119% year-over-year.<b>JD.com</b>(NASDAQ:JD) will own 32.3% of the company after the IPO. The company plans on selling 16.2 million ADSs at a price point of $13 to $15.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ATAI":"ATAI Life Sciences B.V.*","MOLN":"Molecular Partners AG","RERE":"万物新生","WKME":"WalkMe Ltd.","LYEL":"Lyell Immunopharma, Inc.","HKD":"尚乘数科","NVS":"诺华","AOMR":"ANGEL OAK MORTGAGE REIT INC"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175897310","content_text":"This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week.\nAMTD Digital:Asian digital solutions platform AMTD Digital(NYSE:HKD) offers risk solutions and digital insurance technology for partners. The company had revenue of $21.6 million in fiscal 2020 and $18.8 million through the first nine months of the current fiscal year. The company plans to sell 16 million ADSs at a price point of $6.80 to $8.20.\nMolecular Partners:Clinical stage biotechnology company Molecular Partners(NASDAQ:MOLN) isfocusedon using its pioneering DARPin product in categories including infectious diseases, oncology and ophthalmology. The company partnered with Novartis(NYSE:NVS) in 2020,Amgen Inc(NASDAQ:AMGN) in 2018 and AbbVie Inc(NYSE:ABBV) in 2011. Novartis owns 6% of the company. Molecular Partners plans to sell 3 million ADS.\nWalkMe:With a mission to change the way humans interact with technology,WalkMe(NASDAQ:WKME)offerssolutions for organizations. The company has many well-known companies as customers including Nestle and Veolia, two large European companies listed as case studies in the filing.\nWalkMe had revenue of $148 million in 2020 and revenue of $42.7 million in the first quarter of 2021. The company’s revenue was up 34% year-over-year in the last twelve months. The company has 368 customers that represent $100,000 or more in annual revenue and 22 customers that represent $1 million or more in annual revenue. WalkMe plans on selling 9.25 million shares at a price point of $29 to $32.\nConvey Holding:Health care company Convey Holding(NYSE:CNVY)partnerswith eight of the 10 largest Medicare Advantage companies in the U.S. The company had 2.5 million Medicare Advantage and 1.6 million Prescription Drug Plan members in 2020. Revenue in 2020 for the company was $282.9 million. First-quarter 2021 revenue was $82.6 million for the company. Convey Holding plans to sell 13.3 million shares at a price point of $14 to $16.\nAngel Oak Mortgage:Real estate finance company Angel Oak Mortgage(NYSE: AOMR) acquiresand invests in first lien non-QM Loans and other mortgage assets in the U.S. The company had assets of $534.9 million at the end of the first quarter of 2021. The company has elected to be taxed as a REIT. Angel Oak Mortgage is seeking to sell 8.1 million shares at a price point of $20 to $21.\nLyell Immunopharma:Seeking to disrupt the T-cell reprogramming market,Lyell ImmunoPharma(NASDAQ:LYEL)intendsto have four INDs submitted by the end of 2022. The company partnered withGlaxoSmithKline(NYSE:GSK) in 2019 in a deal good for up to $400 million in additional milestones after a $45-million upfront payment.\nGlaxoSmithKline owns 14% of Lyell and Bristol-MyersSquibb(NYSE:BMY) owned Celgene owns 5% of the company. Lyell is planning to sell 25 million shares at a price point of $16 to $18.\nVerve Therapeutics:Genetic medicine companyVerve Therapeutics(NASDAQ: VERV) isfocusedon cardiovascular disease. The company plans to sell 11.8 million shares at a price point of $16 to $18.\nAtai Life Sciences:Backedby Palantir Technologies(NYSE:PLTR) and Paypal Holdings(NASDAQ:PYPL) founder Peter Thiel,Atai Life Sciences(NASDAQ:ATAI) could be one of the high profile IPOs of the week.\nThe company isdevelopingtreatment options for mental health disorders. The company has 10 programs in its pipeline and six enabling technologies. The company is planning on selling 14.3 million shares at a price point of $13 to $15.\nAiHui Shou International:Pre-owned consumer electronics reseller AiHuiShou International(NYSE: RERE)seeksto give a second life to all idle goods.\nThe company’s three business lines — AHS Recycle, PJUT Marketplace and PaiPai Marketplace — help the company as the market leader in China with a market share of 6.6%. The company had revenue of $741.5 million in 2020 and $231.1 million in the first quarter of 2021, up 119% year-over-year.JD.com(NASDAQ:JD) will own 32.3% of the company after the IPO. The company plans on selling 16.2 million ADSs at a price point of $13 to $15.","news_type":1},"isVote":1,"tweetType":1,"viewCount":229,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187171945,"gmtCreate":1623748001487,"gmtModify":1704210297151,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Damnnnn","listText":"Damnnnn","text":"Damnnnn","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187171945","repostId":"2143178756","repostType":4,"repost":{"id":"2143178756","kind":"highlight","pubTimestamp":1623719401,"share":"https://ttm.financial/m/news/2143178756?lang=&edition=fundamental","pubTime":"2021-06-15 09:10","market":"us","language":"en","title":"3 Stocks to Avoid This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2143178756","media":"Motley Fool","summary":"These investments seem pretty vulnerable right now.","content":"<p>In last week's article on three stocks to avoid, I predicted that <b>GameStop</b> (NYSE:GME), <b>AMC Entertainment Holdings</b>&nbsp;(NYSE:AMC), and <b>Carnival</b>&nbsp;(NYSE:CCL) would have a rough few days.</p>\n<ul>\n <li>GameStop lived up to my prediction on tumbling the day after reporting quarterly results, something that has now happened in 10 of the past 11 reports. The video game retailer plummeted 27% on Thursday, but it moved nicely higher the other four days of the week -- trimming its weeklong decline to just 6%.</li>\n <li>AMC closed out the week with a 3% gain, following the 83% burst higher the week before. The multiplex operator is benefiting from a surge in box office receipts, but they continue to track at less than half of where the industry was two years ago.</li>\n <li>Finally we have Carnival sinking 2% for the week. Cruise stocks have been buoyant ahead of a return to sailing this month, but we're already seeing COVID-19 cases pop up in the limited number of voyages taking place so far.</li>\n</ul>\n<p>Those three stocks averaged a 1.7% decline for the week. The <b>S&amp;P 500</b> rose by 0.4% in that time, so I won. Right now, I see <b>Royal Caribbean</b>&nbsp;(NYSE:RCL), AMC Entertainment Holdings, and <b>Osprey Bitcoin Trust</b> (OTC:OBTC) as vulnerable investments in the near term. Here's why I think these are three stocks to avoid this week.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/844fa22418b0d6398103c6917b0d7eb3\" tg-width=\"700\" tg-height=\"459\"><span>Image source: Getty Images.</span></p>\n<h2>1. Royal Caribbean</h2>\n<p>This was supposed to be the summer that the cruise industry finally roars back into being, but we're already seeing some choppy waters. Royal Caribbean's <i>Celebrity Millennium</i> became the first major cruise ship available to North American seafarers earlier this month since the industry shut down last March. A few days into the maiden voyage, a pair of passengers contracted the COVID-19 virus.</p>\n<p>There's also an operational standoff in Royal Caribbean's home state of Florida, where the governor is threatening to fine cruise lines for requiring vaccinations of its passengers. It's a Catch-22 for the industry, as the CDC requires at least 95% of a ship's passengers to be fully vaccinated to resume sailings without having to go through a series of costly test cruises.</p>\n<p>Royal Caribbean is my favorite of the three cruise lines as an investment, but it's also held up the best during the lull. With the reopening off to a bumpy start it also makes the stock vulnerable here.</p>\n<h2><b>2. AMC Entertainment</b></h2>\n<p>I'm a fan of a lot that AMC Entertainment has done to get bet better at a time when many of its smaller rivals have been merely walking in place. The country's largest multiplex operator has upped its seat reservations and mobile order tech and carved out a new revenue stream with actively promoted private rentals. The new Investor Connect program is sheer genius, monetizing its newborn attention as a meme stock with millions of retail investors by trying to convert them into customers.</p>\n<p>However, after ballooning its share count north of 500 million -- and the stock still moving higher -- there will eventually be a price to be paid in terms of valuation. AMC Entertainment enters this week with an enterprise value above $35 billion, and sooner or later someone is going to have to pay the tab at the end of the party.</p>\n<p>AMC is doing the right things to stay on top of a declining industry, but it's not enough to justify today's sticker price.&nbsp; This has historically been a low-margin business -- in the low single digits for net margin most years -- despite the markup on concessions. You'll see a year-over-year bounce this year, but we may never return to 2019 as a baseline. Theatrical release windows are being shattered by streaming initiatives. AMC has bloated its debt levels and share count to stay alive, but all of this comes at a price that right now seems too dear to pay.</p>\n<h2>3. Osprey Bitcoin Trust</h2>\n<p>I believe in keeping a small percent of your risk-tolerant portfolio in crypto, but not every vehicle is in the same boat. Osprey Bitcoin Trust offers investors a low-cost way to play the popularity of <b>Bitcoin</b> (CRYPTO:BTC) in a stock exchange-listed vehicle.</p>\n<p>Osprey Bitcoin Trust is a lot smaller than the market's original Bitcoin-owning trust, and it's also trading at an unsustainable premium. Osprey's mark-up to its stake of Bitcoin tokens has been contracting since hitting the market earlier this year, and I was starting to get interested when the premium narrowed to 12% a week ago.</p>\n<p>The mark-up is going the wrong way again. Osprey Bitcoin Trust owns what is currently $12.68 in Bitcoin, but it closed last week at $14.95. Is an 18% premium worth it when the much larger -- but admittedly more high-cost -- <b>Grayscale Bitcoin Trust</b> (OTC:GBTC) is fetching an 11% discount to its net asset value?</p>\n<p>If you're looking for safe stocks, you aren't likely to find them in Royal Caribbean, AMC Entertainment, and Osprey Bitcoin Trust this week.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Avoid This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Avoid This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/14/3-stocks-to-avoid-this-week/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In last week's article on three stocks to avoid, I predicted that GameStop (NYSE:GME), AMC Entertainment Holdings (NYSE:AMC), and Carnival (NYSE:CCL) would have a rough few days.\n\nGameStop lived up to...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/14/3-stocks-to-avoid-this-week/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","GME":"游戏驿站","OBTC":"Osprey Bitcoin Trust","CCL":"嘉年华邮轮"},"source_url":"https://www.fool.com/investing/2021/06/14/3-stocks-to-avoid-this-week/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143178756","content_text":"In last week's article on three stocks to avoid, I predicted that GameStop (NYSE:GME), AMC Entertainment Holdings (NYSE:AMC), and Carnival (NYSE:CCL) would have a rough few days.\n\nGameStop lived up to my prediction on tumbling the day after reporting quarterly results, something that has now happened in 10 of the past 11 reports. The video game retailer plummeted 27% on Thursday, but it moved nicely higher the other four days of the week -- trimming its weeklong decline to just 6%.\nAMC closed out the week with a 3% gain, following the 83% burst higher the week before. The multiplex operator is benefiting from a surge in box office receipts, but they continue to track at less than half of where the industry was two years ago.\nFinally we have Carnival sinking 2% for the week. Cruise stocks have been buoyant ahead of a return to sailing this month, but we're already seeing COVID-19 cases pop up in the limited number of voyages taking place so far.\n\nThose three stocks averaged a 1.7% decline for the week. The S&P 500 rose by 0.4% in that time, so I won. Right now, I see Royal Caribbean (NYSE:RCL), AMC Entertainment Holdings, and Osprey Bitcoin Trust (OTC:OBTC) as vulnerable investments in the near term. Here's why I think these are three stocks to avoid this week.\nImage source: Getty Images.\n1. Royal Caribbean\nThis was supposed to be the summer that the cruise industry finally roars back into being, but we're already seeing some choppy waters. Royal Caribbean's Celebrity Millennium became the first major cruise ship available to North American seafarers earlier this month since the industry shut down last March. A few days into the maiden voyage, a pair of passengers contracted the COVID-19 virus.\nThere's also an operational standoff in Royal Caribbean's home state of Florida, where the governor is threatening to fine cruise lines for requiring vaccinations of its passengers. It's a Catch-22 for the industry, as the CDC requires at least 95% of a ship's passengers to be fully vaccinated to resume sailings without having to go through a series of costly test cruises.\nRoyal Caribbean is my favorite of the three cruise lines as an investment, but it's also held up the best during the lull. With the reopening off to a bumpy start it also makes the stock vulnerable here.\n2. AMC Entertainment\nI'm a fan of a lot that AMC Entertainment has done to get bet better at a time when many of its smaller rivals have been merely walking in place. The country's largest multiplex operator has upped its seat reservations and mobile order tech and carved out a new revenue stream with actively promoted private rentals. The new Investor Connect program is sheer genius, monetizing its newborn attention as a meme stock with millions of retail investors by trying to convert them into customers.\nHowever, after ballooning its share count north of 500 million -- and the stock still moving higher -- there will eventually be a price to be paid in terms of valuation. AMC Entertainment enters this week with an enterprise value above $35 billion, and sooner or later someone is going to have to pay the tab at the end of the party.\nAMC is doing the right things to stay on top of a declining industry, but it's not enough to justify today's sticker price.  This has historically been a low-margin business -- in the low single digits for net margin most years -- despite the markup on concessions. You'll see a year-over-year bounce this year, but we may never return to 2019 as a baseline. Theatrical release windows are being shattered by streaming initiatives. AMC has bloated its debt levels and share count to stay alive, but all of this comes at a price that right now seems too dear to pay.\n3. Osprey Bitcoin Trust\nI believe in keeping a small percent of your risk-tolerant portfolio in crypto, but not every vehicle is in the same boat. Osprey Bitcoin Trust offers investors a low-cost way to play the popularity of Bitcoin (CRYPTO:BTC) in a stock exchange-listed vehicle.\nOsprey Bitcoin Trust is a lot smaller than the market's original Bitcoin-owning trust, and it's also trading at an unsustainable premium. Osprey's mark-up to its stake of Bitcoin tokens has been contracting since hitting the market earlier this year, and I was starting to get interested when the premium narrowed to 12% a week ago.\nThe mark-up is going the wrong way again. Osprey Bitcoin Trust owns what is currently $12.68 in Bitcoin, but it closed last week at $14.95. Is an 18% premium worth it when the much larger -- but admittedly more high-cost -- Grayscale Bitcoin Trust (OTC:GBTC) is fetching an 11% discount to its net asset value?\nIf you're looking for safe stocks, you aren't likely to find them in Royal Caribbean, AMC Entertainment, and Osprey Bitcoin Trust this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":102,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185502638,"gmtCreate":1623658135724,"gmtModify":1704207966754,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Naked gogogo","listText":"Naked gogogo","text":"Naked gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/185502638","repostId":"1149061517","repostType":2,"isVote":1,"tweetType":1,"viewCount":40,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185273826,"gmtCreate":1623657289865,"gmtModify":1704207946475,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/185273826","repostId":"1105297799","repostType":4,"repost":{"id":"1105297799","kind":"news","pubTimestamp":1623626792,"share":"https://ttm.financial/m/news/1105297799?lang=&edition=fundamental","pubTime":"2021-06-14 07:26","market":"us","language":"en","title":"A Meme Stock Is Born: How to Spot the Next Reddit Favorite","url":"https://stock-news.laohu8.com/highlight/detail?id=1105297799","media":"Bloomberg","summary":"Heavily shorted shares are a common theme among the group. The big stock-price gains often come alongside big drops. While there’s no steadfast definition of what constitutes a meme stock, one common thread across the many names being pitched on social media is a focus on heavily shorted companies. Shares of Reddit iconGameStop Corp.jumped as much as 2,500% in January after day traders noticed its short interest had ballooned to record levels.“I can’t imagine this is going to continue in the sam","content":"<ul>\n <li>Heavily shorted shares are a common theme among the group</li>\n <li>The big stock-price gains often come alongside big drops</li>\n</ul>\n<p>Trying to keep up with the frenzied rise of so-called meme stocks mightfeela bit like playing a game of whack-a-mole, bewildering analysts and investors alike.</p>\n<p>While there’s no steadfast definition of what constitutes a meme stock, one common thread across the many names being pitched on social media is a focus on heavily shorted companies. Shares of Reddit iconGameStop Corp.jumped as much as 2,500% in January after day traders noticed its short interest had ballooned to record levels.</p>\n<p>Investors looking for other stocks that might fit that mold will find nearly 230 firms with a market capitalization of at least $100 million and short interest of 15% or more, according to S3 Partners data compiled by Bloomberg. More than 80% of those names have managed positive returns over the last month with the average gain sitting at about 18%, while the S&amp;P 500 Index rose 2.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/3cc5569937ba7f5b5c78898800cdfdfc\" tg-width=\"773\" tg-height=\"717\"></p>\n<p>Among the most heavily shorted stocks are names like&nbsp;Clover Health Investments Corp.,Workhorse Group Inc.&nbsp;and&nbsp;Geo Group Inc., which have already caught the attention of retail traders in recent days.</p>\n<p>Meanwhile,Bumble Inc.&nbsp;and&nbsp;Petco Health and Wellness Co., both fresh off initial public offerings this year, find themselves on the outside looking in as part of the few companies on the list that haven’t seen outsized gains over the last month. Joining them is ad-tech firmPubMatic Inc., which boasts the highest short interest at 54%, recreational boat retailer MarineMax Inc. and biotech companyBlack Diamond Therapeutics Inc., which has plunged more than 50% over the last month.</p>\n<p><img src=\"https://static.tigerbbs.com/dd6a19a4330894a2f8dfe602f1f76c6a\" tg-width=\"773\" tg-height=\"737\"></p>\n<p>While these sudden rallies can create lucrative returns for investors in the blink of an eye, the extreme volatility that accompanies them can quickly catch traders offside, leaving them holding the bag as shares plunge back to earth.</p>\n<p>After opening the week with a 32% gain, Clover Health’s shares jumped by as much as 142% over the next two days. But, by the close of trading Thursday, anyone who had bought and held shares after Monday’s pop was now underwater.</p>\n<p><img src=\"https://static.tigerbbs.com/bb51208dc3df58cd52f6d1a876bdf594\" tg-width=\"1200\" tg-height=\"675\"></p>\n<p>“I can’t imagine this is going to continue in the same form or fashion for much longer,” said Barry Schwartz, chief investment officer at Baskin Wealth Management. “Just because something is shorted doesn’t mean buying it is going to work out for you,” he added. “You’re playing with fire.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Meme Stock Is Born: How to Spot the Next Reddit Favorite</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Meme Stock Is Born: How to Spot the Next Reddit Favorite\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 07:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-13/a-meme-stock-is-born-how-to-spot-the-next-reddit-favorite?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Heavily shorted shares are a common theme among the group\nThe big stock-price gains often come alongside big drops\n\nTrying to keep up with the frenzied rise of so-called meme stocks mightfeela bit ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-13/a-meme-stock-is-born-how-to-spot-the-next-reddit-favorite?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BMBL":"Bumble Inc.",".IXIC":"NASDAQ Composite","WKHS":"Workhorse Group, Inc.",".SPX":"S&P 500 Index","GEO":"GEO惩教集团","WOOF":"Petco Health and Wellness Company, Inc.","KWITD":"Wellness Matrix Group, Inc.","CLOV":"Clover Health Corp",".DJI":"道琼斯"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-13/a-meme-stock-is-born-how-to-spot-the-next-reddit-favorite?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105297799","content_text":"Heavily shorted shares are a common theme among the group\nThe big stock-price gains often come alongside big drops\n\nTrying to keep up with the frenzied rise of so-called meme stocks mightfeela bit like playing a game of whack-a-mole, bewildering analysts and investors alike.\nWhile there’s no steadfast definition of what constitutes a meme stock, one common thread across the many names being pitched on social media is a focus on heavily shorted companies. Shares of Reddit iconGameStop Corp.jumped as much as 2,500% in January after day traders noticed its short interest had ballooned to record levels.\nInvestors looking for other stocks that might fit that mold will find nearly 230 firms with a market capitalization of at least $100 million and short interest of 15% or more, according to S3 Partners data compiled by Bloomberg. More than 80% of those names have managed positive returns over the last month with the average gain sitting at about 18%, while the S&P 500 Index rose 2.3%.\n\nAmong the most heavily shorted stocks are names like Clover Health Investments Corp.,Workhorse Group Inc. and Geo Group Inc., which have already caught the attention of retail traders in recent days.\nMeanwhile,Bumble Inc. and Petco Health and Wellness Co., both fresh off initial public offerings this year, find themselves on the outside looking in as part of the few companies on the list that haven’t seen outsized gains over the last month. Joining them is ad-tech firmPubMatic Inc., which boasts the highest short interest at 54%, recreational boat retailer MarineMax Inc. and biotech companyBlack Diamond Therapeutics Inc., which has plunged more than 50% over the last month.\n\nWhile these sudden rallies can create lucrative returns for investors in the blink of an eye, the extreme volatility that accompanies them can quickly catch traders offside, leaving them holding the bag as shares plunge back to earth.\nAfter opening the week with a 32% gain, Clover Health’s shares jumped by as much as 142% over the next two days. But, by the close of trading Thursday, anyone who had bought and held shares after Monday’s pop was now underwater.\n\n“I can’t imagine this is going to continue in the same form or fashion for much longer,” said Barry Schwartz, chief investment officer at Baskin Wealth Management. “Just because something is shorted doesn’t mean buying it is going to work out for you,” he added. “You’re playing with fire.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188112615,"gmtCreate":1623423988837,"gmtModify":1704203415153,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Woah naise!","listText":"Woah naise!","text":"Woah naise!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/188112615","repostId":"1158585683","repostType":4,"repost":{"id":"1158585683","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623418302,"share":"https://ttm.financial/m/news/1158585683?lang=&edition=fundamental","pubTime":"2021-06-11 21:31","market":"us","language":"en","title":"Dow rises 80 points, S&P 500 adds to a record as tech shares gain","url":"https://stock-news.laohu8.com/highlight/detail?id=1158585683","media":"Tiger Newspress","summary":"(June 11) U.S. stocks rose on Friday with the S&P 500 adding to its new record, as Wall Street aims ","content":"<p>(June 11)&nbsp;U.S. stocks rose on Friday with the S&amp;P 500 adding to its new record, as Wall Street aims to wrap up the week on a high note.</p>\n<p>The Dow Jones Industrial Average gained 100 points while S&amp;P 500 added 0.2% after closing at a record in the previous session. Nasdaq-100 futures gained 0.1%. Apple, Amazon, Netflix, Microsoft and Alphabet all traded in the green.</p>\n<p>There were not many big movers in premarket trading. Some of the meme stocks were rebounding after a rough day on Thursday. AMC shares were up 3% and GameStop was up 7% in the premarket. Those twosuffered double digit percent losseson Thursday as momentum in the Reddit favorites faded.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow rises 80 points, S&P 500 adds to a record as tech shares gain</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow rises 80 points, S&P 500 adds to a record as tech shares gain\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-11 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 11)&nbsp;U.S. stocks rose on Friday with the S&amp;P 500 adding to its new record, as Wall Street aims to wrap up the week on a high note.</p>\n<p>The Dow Jones Industrial Average gained 100 points while S&amp;P 500 added 0.2% after closing at a record in the previous session. Nasdaq-100 futures gained 0.1%. Apple, Amazon, Netflix, Microsoft and Alphabet all traded in the green.</p>\n<p>There were not many big movers in premarket trading. Some of the meme stocks were rebounding after a rough day on Thursday. AMC shares were up 3% and GameStop was up 7% in the premarket. Those twosuffered double digit percent losseson Thursday as momentum in the Reddit favorites faded.</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158585683","content_text":"(June 11) U.S. stocks rose on Friday with the S&P 500 adding to its new record, as Wall Street aims to wrap up the week on a high note.\nThe Dow Jones Industrial Average gained 100 points while S&P 500 added 0.2% after closing at a record in the previous session. Nasdaq-100 futures gained 0.1%. Apple, Amazon, Netflix, Microsoft and Alphabet all traded in the green.\nThere were not many big movers in premarket trading. Some of the meme stocks were rebounding after a rough day on Thursday. AMC shares were up 3% and GameStop was up 7% in the premarket. Those twosuffered double digit percent losseson Thursday as momentum in the Reddit favorites faded.","news_type":1},"isVote":1,"tweetType":1,"viewCount":84,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":181428755,"gmtCreate":1623408131377,"gmtModify":1704202775635,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Can consider ?&nbsp;","listText":"Can consider ?&nbsp;","text":"Can consider ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/181428755","repostId":"2142268662","repostType":4,"repost":{"id":"2142268662","kind":"highlight","pubTimestamp":1623401730,"share":"https://ttm.financial/m/news/2142268662?lang=&edition=fundamental","pubTime":"2021-06-11 16:55","market":"us","language":"en","title":"After AMC Stock's Surge, Are These 3 Companies Next For Short Squeezes?","url":"https://stock-news.laohu8.com/highlight/detail?id=2142268662","media":"Motley Fool","summary":"Besides being targeted by above-average short interest, these companies are actually growing.","content":"<p>It's been a wildly successful year for some retail investors. Stocks like <b>AMC Entertainment</b> and <b>GameStop</b> have skyrocketed higher because of short squeezes -- meaning that rising share prices have forced investors who've bet against the stocks to close out their positions by buying shares, creating even more upwards pressure on the share prices.</p>\n<p>However, if an underlying business isn't actually growing, a short squeeze is often only a temporary catalyst. Over the long term, this could be the case for AMC and GameStop if their resurgent share prices don't eventually equate to business growth.</p>\n<p>Three other stocks targeted by short-sellers that <i>are </i>growing, however, are <b>CrowdStrike Holdings </b>(NASDAQ:CRWD), <b>Stitch Fix</b> (NASDAQ:SFIX), and <b>PubMatic</b> (NASDAQ:PUBM). Here's why they could be next for a short squeeze.</p>\n<p><img src=\"https://static.tigerbbs.com/2ad8f36275309ed89645631fa95a5156\" tg-width=\"700\" tg-height=\"432\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>1. CrowdStrike: The high-flying cybersecurity firm that can't be grounded</h3>\n<p>Admittedly, CrowdStrike has the lowest short interest of the three companies on this list. Shares sold short (when an investor bets against a company) sit at about 6% of total shares outstanding (the number of shares of a company in circulation), although the figure has been creeping higher in recent months.</p>\n<p>The reason the company is being targeted by short-sellers? CrowdStrike is valued at over 47 times trailing 12-month sales and over 147 times trailing 12-month free cash flow. It's an incredibly lofty premium that prices in double-digit-percentage growth for years to come. And this story isn't new. In the recent past, other cybersecurity firms were off to the races early on as public companies, only to give up their high-growth status just a year or two later. When that happens, shares take a dive. <b>FireEye</b> is just <a href=\"https://laohu8.com/S/AONE\">one</a> example, losing about half of its value back in 2015 when it experienced a fast cool off.</p>\n<p>So far, though, CrowdStrike and its cloud computing-based endpoint security suite have been a very different story. Now a few years out from its IPO, the company is still expanding at a torrid pace. Not only is cloud-based software in high demand, but security that covers employees no matter where they're working is too. And in a digital-first world, new methods to keep data out of the hands of those with nefarious intent is more important than ever.</p>\n<p>This plays right into the hands of CrowdStrike. During the first quarter of fiscal 2022 (the three months ended April 30, 2021), annualized revenue surged 74% higher from a year ago to $1.19 billion. And even as spending to maximize growth stayed high, free cash flow during the period was $117 million -- good for an enviable free cash flow profit margin of nearly 39%.</p>\n<p>CrowdStrike doesn't have the high short interest that sent AMC's stock into the stratosphere, but it is an above-average percentage that could cause the stock to pop if it keeps posting the kind of results it did to kick off its new fiscal year. With cybersecurity needs only expected to keep evolving in complexity in this new cloud era, CrowdStrike has plenty of opportunities ahead of it still.</p>\n<h3>2. Stitch Fix: A resurgence in apparel shopping</h3>\n<p>The world's leading personalized apparel retailer has also been beaten up by short-sellers. Short interest as of this writing is at 12% of shares outstanding, even though consumers are spending heavily on clothing this year after foregoing new threads during pandemic lockdowns in 2020. The U.S. Census Bureau reports apparel spending is up 58% through the end of April.</p>\n<p>A big reason for the bets against this growing apparel company is a downgrade in management's full-fiscal-year guidance back in March -- sales growth expectations were lowered from as much as 25% down to 20%. Plus Stitch Fix stock spiked in value at the start of 2021. Put another way, the company's valuation had gotten ahead of itself, and a pullback was in order.</p>\n<p>However, Stitch Fix is still on the right long-term trajectory, and shares are showing signs of life once again. The stock was up by a double-digit percentage following a stellar fiscal 2021 third-quarter report (the three months ended May 1, 2021). Revenue was up 44% year over year to $536 million as depressed financials from the start of the COVID-19 pandemic were lapped. This is impressive: The company actually remained in growth mode last year even as many of its brick-and-mortar peers suffered. Additionally, full-year sales guidance was adjusted again, this time getting bumped back up to about 21% growth over last year.</p>\n<p><img src=\"https://static.tigerbbs.com/fe75d660c89438e7f2882f675f55176e\" tg-width=\"700\" tg-height=\"700\" referrerpolicy=\"no-referrer\"></p>\n<p>Some of the clothing items from the Spring 2021 kids collection on Stitch Fix.Image source: Stitch Fix.</p>\n<p>Stitch Fix looks like a reasonably valued growth stock after the latest update at just over three times expected current-year revenue. It isn't profitable yet, but if it delivers on its latest financial guidance and continues to grow at a rapid pace as the economy reopens, this stock could soar higher once again.</p>\n<h3>3. PubMatic: An under-the-radar digital advertising platform</h3>\n<p>Digital advertising software firm PubMatic, which had its IPO in December 2020, has also been under attack from short-sellers. As of this writing, about 7% of shares outstanding were sold short. After making its public debut at the end of last year, PubMatic stock soared, nearly tripling in value at <a href=\"https://laohu8.com/S/AONE.U\">one</a> point within a couple of months' time. Suffice to say expectations needed to come back down to earth.</p>\n<p>And that's just what has happened. PubMatic stock is now back where it started in December, but the company itself is off to a great start in 2021. Revenue grew 54% year over year to $43.6 million during the first three months of the year, driven by a net dollar-based retention rate of 130% (implying existing customers spent 30% more on PubMatic's cloud-based ad management software than they did in 2020). The massive migration to TV streaming is at the heart of this huge growth rate, and with most TV ads still being placed via traditional linear formats (like cable), there's still lots of upside here.</p>\n<p>The rate of expansion will accelerate in Q2 as PubMatic also starts to lap financial results from last spring, a period during the first pandemic lockdowns when marketing briefly ground to a halt. PubMatic said to expect revenue to grow at least 70% year-over-year. Add to the mix a robust bottom line (free cash flow was $9.4 million in Q1, or 22% of revenue) and a balance sheet with $1.1 billion in cash and equivalents and no debt, this is one solid cloud software business.</p>\n<p>As of this writing, PubMatic trades for a respective nine and 53 times trailing 12-month sales and free cash flow. That's a pretty good long-term deal for a fast-growing company in an industry benefiting from secular trends as ads and marketing campaigns migrate to online formats. If short sellers start to close out their bets, it could be another tailwind that pushes this stock higher.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After AMC Stock's Surge, Are These 3 Companies Next For Short Squeezes?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter AMC Stock's Surge, Are These 3 Companies Next For Short Squeezes?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 16:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/10/after-amc-surge-companies-next-short-squeeze/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's been a wildly successful year for some retail investors. Stocks like AMC Entertainment and GameStop have skyrocketed higher because of short squeezes -- meaning that rising share prices have ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/10/after-amc-surge-companies-next-short-squeeze/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SFIX":"Stitch Fix Inc.","CRWD":"CrowdStrike Holdings, Inc.","PUBM":"PubMatic, Inc."},"source_url":"https://www.fool.com/investing/2021/06/10/after-amc-surge-companies-next-short-squeeze/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142268662","content_text":"It's been a wildly successful year for some retail investors. Stocks like AMC Entertainment and GameStop have skyrocketed higher because of short squeezes -- meaning that rising share prices have forced investors who've bet against the stocks to close out their positions by buying shares, creating even more upwards pressure on the share prices.\nHowever, if an underlying business isn't actually growing, a short squeeze is often only a temporary catalyst. Over the long term, this could be the case for AMC and GameStop if their resurgent share prices don't eventually equate to business growth.\nThree other stocks targeted by short-sellers that are growing, however, are CrowdStrike Holdings (NASDAQ:CRWD), Stitch Fix (NASDAQ:SFIX), and PubMatic (NASDAQ:PUBM). Here's why they could be next for a short squeeze.\n\nImage source: Getty Images.\n1. CrowdStrike: The high-flying cybersecurity firm that can't be grounded\nAdmittedly, CrowdStrike has the lowest short interest of the three companies on this list. Shares sold short (when an investor bets against a company) sit at about 6% of total shares outstanding (the number of shares of a company in circulation), although the figure has been creeping higher in recent months.\nThe reason the company is being targeted by short-sellers? CrowdStrike is valued at over 47 times trailing 12-month sales and over 147 times trailing 12-month free cash flow. It's an incredibly lofty premium that prices in double-digit-percentage growth for years to come. And this story isn't new. In the recent past, other cybersecurity firms were off to the races early on as public companies, only to give up their high-growth status just a year or two later. When that happens, shares take a dive. FireEye is just one example, losing about half of its value back in 2015 when it experienced a fast cool off.\nSo far, though, CrowdStrike and its cloud computing-based endpoint security suite have been a very different story. Now a few years out from its IPO, the company is still expanding at a torrid pace. Not only is cloud-based software in high demand, but security that covers employees no matter where they're working is too. And in a digital-first world, new methods to keep data out of the hands of those with nefarious intent is more important than ever.\nThis plays right into the hands of CrowdStrike. During the first quarter of fiscal 2022 (the three months ended April 30, 2021), annualized revenue surged 74% higher from a year ago to $1.19 billion. And even as spending to maximize growth stayed high, free cash flow during the period was $117 million -- good for an enviable free cash flow profit margin of nearly 39%.\nCrowdStrike doesn't have the high short interest that sent AMC's stock into the stratosphere, but it is an above-average percentage that could cause the stock to pop if it keeps posting the kind of results it did to kick off its new fiscal year. With cybersecurity needs only expected to keep evolving in complexity in this new cloud era, CrowdStrike has plenty of opportunities ahead of it still.\n2. Stitch Fix: A resurgence in apparel shopping\nThe world's leading personalized apparel retailer has also been beaten up by short-sellers. Short interest as of this writing is at 12% of shares outstanding, even though consumers are spending heavily on clothing this year after foregoing new threads during pandemic lockdowns in 2020. The U.S. Census Bureau reports apparel spending is up 58% through the end of April.\nA big reason for the bets against this growing apparel company is a downgrade in management's full-fiscal-year guidance back in March -- sales growth expectations were lowered from as much as 25% down to 20%. Plus Stitch Fix stock spiked in value at the start of 2021. Put another way, the company's valuation had gotten ahead of itself, and a pullback was in order.\nHowever, Stitch Fix is still on the right long-term trajectory, and shares are showing signs of life once again. The stock was up by a double-digit percentage following a stellar fiscal 2021 third-quarter report (the three months ended May 1, 2021). Revenue was up 44% year over year to $536 million as depressed financials from the start of the COVID-19 pandemic were lapped. This is impressive: The company actually remained in growth mode last year even as many of its brick-and-mortar peers suffered. Additionally, full-year sales guidance was adjusted again, this time getting bumped back up to about 21% growth over last year.\n\nSome of the clothing items from the Spring 2021 kids collection on Stitch Fix.Image source: Stitch Fix.\nStitch Fix looks like a reasonably valued growth stock after the latest update at just over three times expected current-year revenue. It isn't profitable yet, but if it delivers on its latest financial guidance and continues to grow at a rapid pace as the economy reopens, this stock could soar higher once again.\n3. PubMatic: An under-the-radar digital advertising platform\nDigital advertising software firm PubMatic, which had its IPO in December 2020, has also been under attack from short-sellers. As of this writing, about 7% of shares outstanding were sold short. After making its public debut at the end of last year, PubMatic stock soared, nearly tripling in value at one point within a couple of months' time. Suffice to say expectations needed to come back down to earth.\nAnd that's just what has happened. PubMatic stock is now back where it started in December, but the company itself is off to a great start in 2021. Revenue grew 54% year over year to $43.6 million during the first three months of the year, driven by a net dollar-based retention rate of 130% (implying existing customers spent 30% more on PubMatic's cloud-based ad management software than they did in 2020). The massive migration to TV streaming is at the heart of this huge growth rate, and with most TV ads still being placed via traditional linear formats (like cable), there's still lots of upside here.\nThe rate of expansion will accelerate in Q2 as PubMatic also starts to lap financial results from last spring, a period during the first pandemic lockdowns when marketing briefly ground to a halt. PubMatic said to expect revenue to grow at least 70% year-over-year. Add to the mix a robust bottom line (free cash flow was $9.4 million in Q1, or 22% of revenue) and a balance sheet with $1.1 billion in cash and equivalents and no debt, this is one solid cloud software business.\nAs of this writing, PubMatic trades for a respective nine and 53 times trailing 12-month sales and free cash flow. That's a pretty good long-term deal for a fast-growing company in an industry benefiting from secular trends as ads and marketing campaigns migrate to online formats. If short sellers start to close out their bets, it could be another tailwind that pushes this stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":162,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":181429550,"gmtCreate":1623408011070,"gmtModify":1704202772873,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Let’s go!!","listText":"Let’s go!!","text":"Let’s go!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/181429550","repostId":"114899451","repostType":1,"repost":{"id":114899451,"gmtCreate":1623063308869,"gmtModify":1704195267674,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/44a4f89726b3f6319d06a0075bf9ff76","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"36984908995200","authorIdStr":"36984908995200"},"themes":[],"title":"【老虎7週年】集卡瓜分百萬獎金","htmlText":"老虎7週年給大家發福利了，集齊TIGER五個字母即有機會瓜分百萬獎金，你準備好了嗎？ <a href=\"https://www.itiger.com/activity/market/2021/7th-anniversary?lang=zh_CN\" target=\"_blank\">戳我即可參與活動</a> &#x1;如何參與？ 用戶可通過完成活動頁面展示的當日任務列表來獲得字母卡，每完成一個任務即可隨機獲得一個字母，用戶集齊“TIGER”五個字母即可參與瓜分百萬股票代金券，每個用戶單日最多可獲得20張字母卡（不包括好友贈予和魔法卡）。 用戶在活動期間邀請累計7名好友完成註冊並開戶（註冊時間和開戶時間均在活動期間），即可獲得一張魔法卡（每人僅可獲得一張魔法卡）。魔法卡可用於兌換TIGER中的任意一個字母。&#x1;如果用戶的某一字母卡數量爲0，則字母卡爲灰色，用戶可通過點擊灰色的字母卡向好友索要卡片；如果用戶的字母卡數量大於0，則字母卡爲彩色，用戶可通過點擊彩色的字母卡向好友贈送卡片。當用戶集齊TIGER之後將無法再索要卡片或者贈送卡片。 &#x1; &#x1;如何獲得獎勵？ 用戶可在2021年7月1日至2021年7月2日期間進行開獎，所有集齊TIGER的客戶可點擊活動頁面的“開獎”按鈕，即可查看自己瓜分到的股票代金券獎勵。在開獎時間段內未點擊開獎的用戶將無法獲得獎勵。&#x1; 獎勵發放： 股票代金券將在開獎後的1個工作日內發放至用戶的獎勵中心，用戶需要在獎勵發放後的20天內前往【Tiger Trade APP &gt; 我的 &gt; 活動獎勵】領取，過期未領取的獎勵將自動失效。 重要提示： 本次7週年活動涉及不同國家和地區，由於各地區的監管要求不同，不同地區的活動獎勵會有所區別。欲知詳情，請點擊下方活動鏈接，登陸您的賬號，並點擊“活動規則“查看詳情。","listText":"老虎7週年給大家發福利了，集齊TIGER五個字母即有機會瓜分百萬獎金，你準備好了嗎？ <a href=\"https://www.itiger.com/activity/market/2021/7th-anniversary?lang=zh_CN\" target=\"_blank\">戳我即可參與活動</a> &#x1;如何參與？ 用戶可通過完成活動頁面展示的當日任務列表來獲得字母卡，每完成一個任務即可隨機獲得一個字母，用戶集齊“TIGER”五個字母即可參與瓜分百萬股票代金券，每個用戶單日最多可獲得20張字母卡（不包括好友贈予和魔法卡）。 用戶在活動期間邀請累計7名好友完成註冊並開戶（註冊時間和開戶時間均在活動期間），即可獲得一張魔法卡（每人僅可獲得一張魔法卡）。魔法卡可用於兌換TIGER中的任意一個字母。&#x1;如果用戶的某一字母卡數量爲0，則字母卡爲灰色，用戶可通過點擊灰色的字母卡向好友索要卡片；如果用戶的字母卡數量大於0，則字母卡爲彩色，用戶可通過點擊彩色的字母卡向好友贈送卡片。當用戶集齊TIGER之後將無法再索要卡片或者贈送卡片。 &#x1; &#x1;如何獲得獎勵？ 用戶可在2021年7月1日至2021年7月2日期間進行開獎，所有集齊TIGER的客戶可點擊活動頁面的“開獎”按鈕，即可查看自己瓜分到的股票代金券獎勵。在開獎時間段內未點擊開獎的用戶將無法獲得獎勵。&#x1; 獎勵發放： 股票代金券將在開獎後的1個工作日內發放至用戶的獎勵中心，用戶需要在獎勵發放後的20天內前往【Tiger Trade APP &gt; 我的 &gt; 活動獎勵】領取，過期未領取的獎勵將自動失效。 重要提示： 本次7週年活動涉及不同國家和地區，由於各地區的監管要求不同，不同地區的活動獎勵會有所區別。欲知詳情，請點擊下方活動鏈接，登陸您的賬號，並點擊“活動規則“查看詳情。","text":"老虎7週年給大家發福利了，集齊TIGER五個字母即有機會瓜分百萬獎金，你準備好了嗎？ 戳我即可參與活動 \u0001如何參與？ 用戶可通過完成活動頁面展示的當日任務列表來獲得字母卡，每完成一個任務即可隨機獲得一個字母，用戶集齊“TIGER”五個字母即可參與瓜分百萬股票代金券，每個用戶單日最多可獲得20張字母卡（不包括好友贈予和魔法卡）。 用戶在活動期間邀請累計7名好友完成註冊並開戶（註冊時間和開戶時間均在活動期間），即可獲得一張魔法卡（每人僅可獲得一張魔法卡）。魔法卡可用於兌換TIGER中的任意一個字母。\u0001如果用戶的某一字母卡數量爲0，則字母卡爲灰色，用戶可通過點擊灰色的字母卡向好友索要卡片；如果用戶的字母卡數量大於0，則字母卡爲彩色，用戶可通過點擊彩色的字母卡向好友贈送卡片。當用戶集齊TIGER之後將無法再索要卡片或者贈送卡片。 \u0001 \u0001如何獲得獎勵？ 用戶可在2021年7月1日至2021年7月2日期間進行開獎，所有集齊TIGER的客戶可點擊活動頁面的“開獎”按鈕，即可查看自己瓜分到的股票代金券獎勵。在開獎時間段內未點擊開獎的用戶將無法獲得獎勵。\u0001 獎勵發放： 股票代金券將在開獎後的1個工作日內發放至用戶的獎勵中心，用戶需要在獎勵發放後的20天內前往【Tiger Trade APP > 我的 > 活動獎勵】領取，過期未領取的獎勵將自動失效。 重要提示： 本次7週年活動涉及不同國家和地區，由於各地區的監管要求不同，不同地區的活動獎勵會有所區別。欲知詳情，請點擊下方活動鏈接，登陸您的賬號，並點擊“活動規則“查看詳情。","images":[{"img":"https://static.tigerbbs.com/fd956a9c2fc9ee609753ae5f967072a7","width":"415","height":"616"},{"img":"https://static.tigerbbs.com/92e88357b534f504b3088bc22f577a83","width":"415","height":"326"},{"img":"https://static.tigerbbs.com/fe0400cc487fb56f85d401ab03df4d5e","width":"415","height":"356"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/114899451","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":8,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":82,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":181460810,"gmtCreate":1623407462830,"gmtModify":1704202756952,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Woooo hooo ??&nbsp;","listText":"Woooo hooo ??&nbsp;","text":"Woooo hooo ??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/181460810","repostId":"1138970454","repostType":2,"repost":{"id":"1138970454","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623385949,"share":"https://ttm.financial/m/news/1138970454?lang=&edition=fundamental","pubTime":"2021-06-11 12:32","market":"us","language":"en","title":"Tiger Broker has been honoured The Asset Triple A Sustainable Investing Awards 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1138970454","media":"Tiger Newspress","summary":"June 11/ Tiger Broker has been honoured with the following awared at The Asset Triple A Sustainable ","content":"<p>June&nbsp;11/&nbsp;Tiger Broker has been honoured with&nbsp;the&nbsp;following&nbsp;awared&nbsp;at&nbsp;The Asset Triple A Sustainable Investing Awards 2021&nbsp;for&nbsp;Institutional&nbsp;Investor,&nbsp;ETF&nbsp;and&nbsp;Asset&nbsp;Servicing&nbsp;Providers:</p><p><img src=\"https://static.tigerbbs.com/d2a1d625f288fc86245344e0a6275f6f\" tg-width=\"1096\" tg-height=\"354\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tiger Broker has been honoured The Asset Triple A Sustainable Investing Awards 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTiger Broker has been honoured The Asset Triple A Sustainable Investing Awards 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-11 12:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>June&nbsp;11/&nbsp;Tiger Broker has been honoured with&nbsp;the&nbsp;following&nbsp;awared&nbsp;at&nbsp;The Asset Triple A Sustainable Investing Awards 2021&nbsp;for&nbsp;Institutional&nbsp;Investor,&nbsp;ETF&nbsp;and&nbsp;Asset&nbsp;Servicing&nbsp;Providers:</p><p><img src=\"https://static.tigerbbs.com/d2a1d625f288fc86245344e0a6275f6f\" tg-width=\"1096\" tg-height=\"354\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TIGR":"老虎证券"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138970454","content_text":"June 11/ Tiger Broker has been honoured with the following awared at The Asset Triple A Sustainable Investing Awards 2021 for Institutional Investor, ETF and Asset Servicing Providers:","news_type":1},"isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183610076,"gmtCreate":1623327680095,"gmtModify":1704200950980,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Buy buy buy!! Fly fly fly!!!","listText":"Buy buy buy!! Fly fly fly!!!","text":"Buy buy buy!! Fly fly fly!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183610076","repostId":"1111571294","repostType":2,"isVote":1,"tweetType":1,"viewCount":180,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114418584,"gmtCreate":1623086809648,"gmtModify":1704195848023,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"That’s the way uh huh uh huh~","listText":"That’s the way uh huh uh huh~","text":"That’s the way uh huh uh huh~","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/114418584","repostId":"2141239873","repostType":2,"repost":{"id":"2141239873","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623062347,"share":"https://ttm.financial/m/news/2141239873?lang=&edition=fundamental","pubTime":"2021-06-07 18:39","market":"us","language":"en","title":"BRIEF-Ocugen Says Co And Bharat Entered Into That Certain First Amendment To Co-Development, Supply And Commercialization Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2141239873","media":"Reuters","summary":"June 7 (Reuters) - Ocugen Inc   :   * OCUGEN INC - ON JUNE 1, 2021, CO AND BHARAT ENTERED INTO THAT ","content":"<html><body><p>June 7 (Reuters) - Ocugen Inc   :</p><p>   * OCUGEN INC - ON JUNE 1, 2021, CO AND BHARAT ENTERED INTO THAT CERTAIN FIRST AMENDMENT TO CO-DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENT</p><p>   * OCUGEN INC - PARTIES AGREED TO EXPAND THE ORIGINAL OCUGEN TERRITORY TO INCLUDE THE UNITED STATES AND CANADA</p><p>   * OCUGEN INC -  PAID TO BHARAT $15 MILLION IMMEDIATELY UPON EXECUTION OF THE AMENDMENT</p><p>   * OCUGEN INC - FURTHER AGREED TO PAY TO BHARAT A MILESTONE PAYMENT OF $10 MILLION WITHIN 30 DAYS OF THE FIRST COMMERCIAL SALE OF COVAXIN IN CANADA.</p><p>   * OCUGEN INC -  PARTIES WILL SHARE ANY PROFITS GENERATED FROM THE COMMERCIALIZATION OF COVAXIN IN THE AMENDED OCUGEN TERRITORY</p><p>Source text () Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Ocugen Says Co And Bharat Entered Into That Certain First Amendment To Co-Development, Supply And Commercialization Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Ocugen Says Co And Bharat Entered Into That Certain First Amendment To Co-Development, Supply And Commercialization Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-07 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>June 7 (Reuters) - Ocugen Inc   :</p><p>   * OCUGEN INC - ON JUNE 1, 2021, CO AND BHARAT ENTERED INTO THAT CERTAIN FIRST AMENDMENT TO CO-DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENT</p><p>   * OCUGEN INC - PARTIES AGREED TO EXPAND THE ORIGINAL OCUGEN TERRITORY TO INCLUDE THE UNITED STATES AND CANADA</p><p>   * OCUGEN INC -  PAID TO BHARAT $15 MILLION IMMEDIATELY UPON EXECUTION OF THE AMENDMENT</p><p>   * OCUGEN INC - FURTHER AGREED TO PAY TO BHARAT A MILESTONE PAYMENT OF $10 MILLION WITHIN 30 DAYS OF THE FIRST COMMERCIAL SALE OF COVAXIN IN CANADA.</p><p>   * OCUGEN INC -  PARTIES WILL SHARE ANY PROFITS GENERATED FROM THE COMMERCIALIZATION OF COVAXIN IN THE AMENDED OCUGEN TERRITORY</p><p>Source text () Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"THFF":"First Financial Corporation Indi","OCGN":"Ocugen","FBNC":"第一万能金控","FNLC":"第一万通金控","FFBC":"第一金融银行股份"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2141239873","content_text":"June 7 (Reuters) - Ocugen Inc   :   * OCUGEN INC - ON JUNE 1, 2021, CO AND BHARAT ENTERED INTO THAT CERTAIN FIRST AMENDMENT TO CO-DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENT   * OCUGEN INC - PARTIES AGREED TO EXPAND THE ORIGINAL OCUGEN TERRITORY TO INCLUDE THE UNITED STATES AND CANADA   * OCUGEN INC -  PAID TO BHARAT $15 MILLION IMMEDIATELY UPON EXECUTION OF THE AMENDMENT   * OCUGEN INC - FURTHER AGREED TO PAY TO BHARAT A MILESTONE PAYMENT OF $10 MILLION WITHIN 30 DAYS OF THE FIRST COMMERCIAL SALE OF COVAXIN IN CANADA.   * OCUGEN INC -  PARTIES WILL SHARE ANY PROFITS GENERATED FROM THE COMMERCIALIZATION OF COVAXIN IN THE AMENDED OCUGEN TERRITORYSource text () Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":132114117,"gmtCreate":1622075651639,"gmtModify":1704178897919,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"May it be approved soon then~ the discussion has been way too long.. already no joy upon the news, only the actual graph can excite","listText":"May it be approved soon then~ the discussion has been way too long.. already no joy upon the news, only the actual graph can excite","text":"May it be approved soon then~ the discussion has been way too long.. already no joy upon the news, only the actual graph can excite","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/132114117","repostId":"2138144615","repostType":2,"repost":{"id":"2138144615","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1622075143,"share":"https://ttm.financial/m/news/2138144615?lang=&edition=fundamental","pubTime":"2021-05-27 08:25","market":"us","language":"en","title":"BRIEF-Ocugen Says On Track To Submit EUA Application To U.S. FDA For Its COVID-19 Vaccine Candidate, Covaxin","url":"https://stock-news.laohu8.com/highlight/detail?id=2138144615","media":"Reuters","summary":"May 26 (Reuters) - Ocugen Inc   :   * OCUGEN ON TRACK TO SUBMIT EMERGENCY USE AUTHORIZATION APPLICAT","content":"<html><body><p>May 26 (Reuters) - Ocugen Inc   :</p><p>   * OCUGEN ON TRACK TO SUBMIT EMERGENCY USE AUTHORIZATION APPLICATION TO U.S. FDA FOR ITS COVID-19 VACCINE CANDIDATE, COVAXIN</p><p>   * ACTIVE DISCUSSIONS WITH FDA RELATED TO COVAXIN INITIATED LATE LAST YEAR</p><p>   * MASTER FILE SUBMITTED TO FDA ON MARCH 26, 2021; AWAITING <a href=\"https://laohu8.com/S/FDBK.UK\">FEEDBACK</a> FROM FDA</p><p>   * CONFIRMED ITS PLAN TO SUBMIT ITS EUA APPLICATION FOR COVAXIN TO U.S. FOOD &amp; DRUG ADMINISTRATION (FDA) IN JUNE</p><p>   * BELIEVE THAT FDA'S NEW GUIDANCE CONFIRMS THAT OCUGEN CONTINUES TO MEET ALL CRITERIA FOR SUBMISSION OF AN EUA</p><p>   * ONCE EUA APPLICATION HAS BEEN SUBMITTED, OCUGEN INTENDS TO COMMENCE PRE-BIOLOGICS LICENSE APPLICATION DISCUSSIONS WITH FDA</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Ocugen Says On Track To Submit EUA Application To U.S. FDA For Its COVID-19 Vaccine Candidate, Covaxin</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Ocugen Says On Track To Submit EUA Application To U.S. FDA For Its COVID-19 Vaccine Candidate, Covaxin\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-05-27 08:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>May 26 (Reuters) - Ocugen Inc   :</p><p>   * OCUGEN ON TRACK TO SUBMIT EMERGENCY USE AUTHORIZATION APPLICATION TO U.S. FDA FOR ITS COVID-19 VACCINE CANDIDATE, COVAXIN</p><p>   * ACTIVE DISCUSSIONS WITH FDA RELATED TO COVAXIN INITIATED LATE LAST YEAR</p><p>   * MASTER FILE SUBMITTED TO FDA ON MARCH 26, 2021; AWAITING <a href=\"https://laohu8.com/S/FDBK.UK\">FEEDBACK</a> FROM FDA</p><p>   * CONFIRMED ITS PLAN TO SUBMIT ITS EUA APPLICATION FOR COVAXIN TO U.S. FOOD &amp; DRUG ADMINISTRATION (FDA) IN JUNE</p><p>   * BELIEVE THAT FDA'S NEW GUIDANCE CONFIRMS THAT OCUGEN CONTINUES TO MEET ALL CRITERIA FOR SUBMISSION OF AN EUA</p><p>   * ONCE EUA APPLICATION HAS BEEN SUBMITTED, OCUGEN INTENDS TO COMMENCE PRE-BIOLOGICS LICENSE APPLICATION DISCUSSIONS WITH FDA</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2138144615","content_text":"May 26 (Reuters) - Ocugen Inc   :   * OCUGEN ON TRACK TO SUBMIT EMERGENCY USE AUTHORIZATION APPLICATION TO U.S. FDA FOR ITS COVID-19 VACCINE CANDIDATE, COVAXIN   * ACTIVE DISCUSSIONS WITH FDA RELATED TO COVAXIN INITIATED LATE LAST YEAR   * MASTER FILE SUBMITTED TO FDA ON MARCH 26, 2021; AWAITING FEEDBACK FROM FDA   * CONFIRMED ITS PLAN TO SUBMIT ITS EUA APPLICATION FOR COVAXIN TO U.S. FOOD & DRUG ADMINISTRATION (FDA) IN JUNE   * BELIEVE THAT FDA'S NEW GUIDANCE CONFIRMS THAT OCUGEN CONTINUES TO MEET ALL CRITERIA FOR SUBMISSION OF AN EUA   * ONCE EUA APPLICATION HAS BEEN SUBMITTED, OCUGEN INTENDS TO COMMENCE PRE-BIOLOGICS LICENSE APPLICATION DISCUSSIONS WITH FDASource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":139,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":100432838,"gmtCreate":1619627690324,"gmtModify":1704727100914,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>FDA kindly approve histo for emergency use ?????","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>FDA kindly approve histo for emergency use ?????","text":"$Histogenics(OCGN)$FDA kindly approve histo for emergency use ?????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/100432838","isVote":1,"tweetType":1,"viewCount":667,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578811676095048","authorId":"3578811676095048","name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","crmLevel":7,"crmLevelSwitch":0,"idStr":"3578811676095048","authorIdStr":"3578811676095048"},"content":"Yes! Finally its coming. stock pipling fOr more Guys!","text":"Yes! Finally its coming. stock pipling fOr more Guys!","html":"Yes! Finally its coming. stock pipling fOr more Guys!"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106431901,"gmtCreate":1620138145403,"gmtModify":1704339194483,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>FDA &amp; EUA soon ???????","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>FDA &amp; EUA soon ???????","text":"$Histogenics(OCGN)$FDA & EUA soon ???????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/106431901","isVote":1,"tweetType":1,"viewCount":165,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":108770729,"gmtCreate":1620058417161,"gmtModify":1704338075101,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RVPH\">$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$</a>Phase 3 trail gotta succeed soon! Comeon! ???????","listText":"<a href=\"https://laohu8.com/S/RVPH\">$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$</a>Phase 3 trail gotta succeed soon! Comeon! ???????","text":"$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$Phase 3 trail gotta succeed soon! Comeon! ???????","images":[{"img":"https://static.tigerbbs.com/c65f9d0a9f97db6e86abf4e90d81ce1c","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/108770729","isVote":1,"tweetType":1,"viewCount":308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":106432481,"gmtCreate":1620138340243,"gmtModify":1704339198599,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>Where’s the Reddit push to $100? Hahahah","listText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>Where’s the Reddit push to $100? Hahahah","text":"$Microvision(MVIS)$Where’s the Reddit push to $100? Hahahah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/106432481","isVote":1,"tweetType":1,"viewCount":509,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3499670714821455","authorId":"3499670714821455","name":"Pherson","avatar":"https://static.tigerbbs.com/ac65897b5fc1c9a26e94c39d30108b35","crmLevel":1,"crmLevelSwitch":0,"idStr":"3499670714821455","authorIdStr":"3499670714821455"},"content":"I said 10000 letter or not","text":"I said 10000 letter or not","html":"I said 10000 letter or not"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106430920,"gmtCreate":1620137959860,"gmtModify":1704339191183,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RVPH\">$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$</a>Silent for way too long~ something should be cooking soon!!","listText":"<a href=\"https://laohu8.com/S/RVPH\">$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$</a>Silent for way too long~ something should be cooking soon!!","text":"$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$Silent for way too long~ something should be cooking soon!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/106430920","isVote":1,"tweetType":1,"viewCount":427,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578811676095048","authorId":"3578811676095048","name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","crmLevel":7,"crmLevelSwitch":0,"idStr":"3578811676095048","authorIdStr":"3578811676095048"},"content":"Yea, i am sensing that too. Buying More to leverage!","text":"Yea, i am sensing that too. Buying More to leverage!","html":"Yea, i am sensing that too. Buying More to leverage!"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164587366,"gmtCreate":1624230013555,"gmtModify":1703830813306,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Note to self~","listText":"Note to self~","text":"Note to self~","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164587366","repostId":"1126454279","repostType":2,"repost":{"id":"1126454279","kind":"news","pubTimestamp":1624151746,"share":"https://ttm.financial/m/news/1126454279?lang=&edition=fundamental","pubTime":"2021-06-20 09:15","market":"us","language":"en","title":"A Stock Market Crash Is Coming: 5 High-Conviction Stocks to Buy Hand Over Fist When It Happens","url":"https://stock-news.laohu8.com/highlight/detail?id=1126454279","media":"fool","summary":"It might be the last thing you want to hear, but it's the truth:A stock market crash is inevitable.\n","content":"<p>It might be the last thing you want to hear, but it's the truth:A stock market crash is inevitable.</p>\n<p>Since the March 23, 2020 bottom, investors have enjoyed a historically strong bounce-back rally -- the widely followed<b>S&amp;P 500</b>(SNPINDEX:^GSPC)has gained an impressive 90%. But both history and valuation metrics unequivocally suggest that a big drop is upcoming for the stock market.</p>\n<p><b>History is pretty clear that trouble lies ahead</b></p>\n<p>For example, there have beenone or two double-digit percentage declineswithin the three years following a bottom in each of the previous eight bear markets prior to the coronavirus crash (i.e., dating back to 1960). Although bull markets tend to last years, rebounds from a bear market are never this smooth. We're nearly 15 months past the March 2020 bear-market bottom in the S&amp;P 500 and have yet to see anything close to a double-digit correction.</p>\n<p>To add to this point, data from market analytics firm Yardeni Research shows that there have been 38 double-digit declines in the S&amp;P 500 over the past 71 years. That's a crash or correction, on average,every 1.87 years. Though the market doesn't adhere to averages, it does give a general sense of when to expect these hiccups.</p>\n<p>On a valuation basis, the S&amp;P 500's Shiller price-to-earnings (P/E) ratio is a waving red flag. The S&amp;P 500's Shiller P/E -- a measure of inflation-adjusted earnings over the previous 10 years -- almost hit 38 earlier this week. That more than doubles its 151-year average, and it's the highest level in nearly two decades. The previous four times the Shiller P/E surpassed and held above 30 during a bull market rally, the indexsubsequently declined by a minimum of 20%.</p>\n<p>Make no mistake about it -- a stock market crash is coming.</p>\n<p>Every crash or correction is an opportunity for patient investors to make money</p>\n<p>However, a crash is no reason to duck and cover. While history may signal trouble ahead, it also tells us that each and every double-digit decline has been a buying opportunity. Eventually, every big drop in the major indexes is erased by a bull-market rally. When the next crash does occur, the following five high-conviction stocks can be confidently bought hand over fist.</p>\n<p><b>CrowdStrike Holdings</b></p>\n<p>Cybersecurity is projected to beone of the safest double-digit growth trendsthis decade. No matter the size of the business or the state of the U.S./global economy, protecting enterprise and consumer data is paramount. This means cloud-based cybersecurity stock<b>CrowdStrike Holdings</b>(NASDAQ:CRWD)can thrive in any environment.</p>\n<p>CrowdStrike's successderives from its cloud-native Falcon security platform. Because it's built in the cloud and relies on artificial intelligence, it's growing smarter at identifying and responding to threats all the time. It's currently overseeing 6 trillion events on a weekly basis, and it's far more cost-effective at protecting data than on-premise solutions.</p>\n<p>We can also look to the company's income statements to see clear-cut evidence that businesses favor CrowdStrike's cybersecurity platform. It's been retaining 98% of its clients, has seen existing clients spend 23% to 47% more on a year-over-year basis for the past 12 quarters, and recently reported that 64% of its customers have purchased at least four cloud module subscriptions. Scaling with its customers is CrowdStrike's ticket to big-time cash flow expansion.</p>\n<p><b>Facebook</b></p>\n<p>Brand-name businesses can make patient investors a fortune, and social media giant<b>Facebook</b>(NASDAQ:FB)is the perfect example.</p>\n<p>When the curtain closed on March, Facebook tallied 2.85 billion monthly active users (MAU) visiting its namesake site and an additional 600 million unique MAUs visiting WhatsApp or Instagram, which it also owns. All told, this equates to44% of the global populationinteracting with its owned sites each month. There's simply no social media platform businesses can go to get their message to a broader (or potentially targeted) audience, which is why Facebook ad-pricing power is so strong.</p>\n<p>But here's the kicker: Facebookhasn't even put the pedal to the metal. Although it's on track to generate more than $100 billion in advertising revenue in 2021, nearly all of these ad sales are coming from its namesake site and Instagram. WhatsApp and Facebook Messenger, which are two of the six most-visited social sites in the world, aren't being meaningfully monetized as of yet. Further, the company's Oculus virtual reality devices are still in the early stage of their growth. Suffice it to say, Facebook offers ample upside as its other operating segments are monetized and mature.</p>\n<p><b>NextEra Energy</b></p>\n<p>Another high-conviction stock to buy hand over fist the next time a crash or steep correction strikes is electric utility stock<b>NextEra Energy</b>(NYSE:NEE).</p>\n<p>Did I put you to sleep when I said \"electric utility stock?\" Electric utilities are traditionally known for their market-topping dividend yields and persistently low growth rates. But this doesn't describe NextEra Energy. NextEra has aggressively invested in renewable energy projects and is leading the country in solar and wind capacity. As a result of these investments, its electric generation costs have declined and its compound annual growth ratehas consistently been in the high single digitsfor more than a decade. It also doesn't hurt that NextEra is front-running any potential green-energy legislation that might come out of Washington.</p>\n<p>In addition to growth rates that are well above the sector average, NextEra still benefits from the predictability of energy demand. For instance, its regulated utilities (i.e., those not powered by renewable energy) require approval from state utility commissions before price hikes can be passed along to households. This might sound like an inconvenience, but it's actually great news. It means NextEra won't be exposed to potentially volatile wholesale pricing.</p>\n<p><b>Visa</b></p>\n<p>When the next stock market crash arrives, payment processing kingpin<b>Visa</b>(NYSE:V)is a winning company to confidently buy hand over fist. It's also another brand-name company thatcan still make its shareholders a fortune.</p>\n<p>Buying into the Visa growth story is a simple numbers game. Visa grows its revenue and profits when consumers and businesses are spending more. This happens when the U.S. and global economy are expanding. Although contractions and recessions are an inevitable part of the economic cycle, they tend to be short-lived. Meanwhile, periods of economic expansion are almost always measured in years. Buying into Visa during these short-lived crashes or corrections should allow long-term investors to be handsomely rewarded by this numbers game.</p>\n<p>The other interesting thing about Visa is thatit's shunned becoming a lender. You'd think that Visa could generate big bucks from interest income and fees by lending during these long-lived periods of expansion. But lending would also expose Visa to the credit delinquencies that arise during recessions. Operating solely as a payment processor means not having to set aside cash to cover delinquencies. It's why Visa rebounds so much faster than most financial stocks following a recession.</p>\n<p><b>Amazon</b></p>\n<p>Lastly (andwho couldn't see this coming?), investors should take any discount they can get during a crash on e-commerce behemoth<b>Amazon</b>(NASDAQ:AMZN).</p>\n<p>Amazon's online marketplace has proved virtually unstoppable for well over a decade. An April 2021 report from eMarketer pegged the company's share of U.S. online sales at 40.4%. That more than quintuples its next-closest competitor and effectively solidifies Amazon as the go-to source for online shopping in the U.S.</p>\n<p>What about those pesky low retail margins, you ask? Amazon has signed up more than 200 million people globally to a Prime membership. The fees collected from Prime members help to offset some of the company's retail-based margin weakness. Prime members are extremely loyal to the Amazon ecosystem and spend far more than non-members, too.</p>\n<p>But it's Amazon's cloud infrastructure segmentthat's the superstar. Amazon Web Services (AWS) brings in around one-eighth of the company's total sales but accounts for well over half its operating income. Since cloud margins are superior to retail and advertising margins, AWS is the company's key to explosive cash flow growth this decade.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Stock Market Crash Is Coming: 5 High-Conviction Stocks to Buy Hand Over Fist When It Happens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Stock Market Crash Is Coming: 5 High-Conviction Stocks to Buy Hand Over Fist When It Happens\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-20 09:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/19/stock-market-crash-coming-5-high-conviction-stocks/><strong>fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It might be the last thing you want to hear, but it's the truth:A stock market crash is inevitable.\nSince the March 23, 2020 bottom, investors have enjoyed a historically strong bounce-back rally -- ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/19/stock-market-crash-coming-5-high-conviction-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NEP":"Nextera Energy Partners","V":"Visa","CRWD":"CrowdStrike Holdings, Inc.","AMZN":"亚马逊"},"source_url":"https://www.fool.com/investing/2021/06/19/stock-market-crash-coming-5-high-conviction-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126454279","content_text":"It might be the last thing you want to hear, but it's the truth:A stock market crash is inevitable.\nSince the March 23, 2020 bottom, investors have enjoyed a historically strong bounce-back rally -- the widely followedS&P 500(SNPINDEX:^GSPC)has gained an impressive 90%. But both history and valuation metrics unequivocally suggest that a big drop is upcoming for the stock market.\nHistory is pretty clear that trouble lies ahead\nFor example, there have beenone or two double-digit percentage declineswithin the three years following a bottom in each of the previous eight bear markets prior to the coronavirus crash (i.e., dating back to 1960). Although bull markets tend to last years, rebounds from a bear market are never this smooth. We're nearly 15 months past the March 2020 bear-market bottom in the S&P 500 and have yet to see anything close to a double-digit correction.\nTo add to this point, data from market analytics firm Yardeni Research shows that there have been 38 double-digit declines in the S&P 500 over the past 71 years. That's a crash or correction, on average,every 1.87 years. Though the market doesn't adhere to averages, it does give a general sense of when to expect these hiccups.\nOn a valuation basis, the S&P 500's Shiller price-to-earnings (P/E) ratio is a waving red flag. The S&P 500's Shiller P/E -- a measure of inflation-adjusted earnings over the previous 10 years -- almost hit 38 earlier this week. That more than doubles its 151-year average, and it's the highest level in nearly two decades. The previous four times the Shiller P/E surpassed and held above 30 during a bull market rally, the indexsubsequently declined by a minimum of 20%.\nMake no mistake about it -- a stock market crash is coming.\nEvery crash or correction is an opportunity for patient investors to make money\nHowever, a crash is no reason to duck and cover. While history may signal trouble ahead, it also tells us that each and every double-digit decline has been a buying opportunity. Eventually, every big drop in the major indexes is erased by a bull-market rally. When the next crash does occur, the following five high-conviction stocks can be confidently bought hand over fist.\nCrowdStrike Holdings\nCybersecurity is projected to beone of the safest double-digit growth trendsthis decade. No matter the size of the business or the state of the U.S./global economy, protecting enterprise and consumer data is paramount. This means cloud-based cybersecurity stockCrowdStrike Holdings(NASDAQ:CRWD)can thrive in any environment.\nCrowdStrike's successderives from its cloud-native Falcon security platform. Because it's built in the cloud and relies on artificial intelligence, it's growing smarter at identifying and responding to threats all the time. It's currently overseeing 6 trillion events on a weekly basis, and it's far more cost-effective at protecting data than on-premise solutions.\nWe can also look to the company's income statements to see clear-cut evidence that businesses favor CrowdStrike's cybersecurity platform. It's been retaining 98% of its clients, has seen existing clients spend 23% to 47% more on a year-over-year basis for the past 12 quarters, and recently reported that 64% of its customers have purchased at least four cloud module subscriptions. Scaling with its customers is CrowdStrike's ticket to big-time cash flow expansion.\nFacebook\nBrand-name businesses can make patient investors a fortune, and social media giantFacebook(NASDAQ:FB)is the perfect example.\nWhen the curtain closed on March, Facebook tallied 2.85 billion monthly active users (MAU) visiting its namesake site and an additional 600 million unique MAUs visiting WhatsApp or Instagram, which it also owns. All told, this equates to44% of the global populationinteracting with its owned sites each month. There's simply no social media platform businesses can go to get their message to a broader (or potentially targeted) audience, which is why Facebook ad-pricing power is so strong.\nBut here's the kicker: Facebookhasn't even put the pedal to the metal. Although it's on track to generate more than $100 billion in advertising revenue in 2021, nearly all of these ad sales are coming from its namesake site and Instagram. WhatsApp and Facebook Messenger, which are two of the six most-visited social sites in the world, aren't being meaningfully monetized as of yet. Further, the company's Oculus virtual reality devices are still in the early stage of their growth. Suffice it to say, Facebook offers ample upside as its other operating segments are monetized and mature.\nNextEra Energy\nAnother high-conviction stock to buy hand over fist the next time a crash or steep correction strikes is electric utility stockNextEra Energy(NYSE:NEE).\nDid I put you to sleep when I said \"electric utility stock?\" Electric utilities are traditionally known for their market-topping dividend yields and persistently low growth rates. But this doesn't describe NextEra Energy. NextEra has aggressively invested in renewable energy projects and is leading the country in solar and wind capacity. As a result of these investments, its electric generation costs have declined and its compound annual growth ratehas consistently been in the high single digitsfor more than a decade. It also doesn't hurt that NextEra is front-running any potential green-energy legislation that might come out of Washington.\nIn addition to growth rates that are well above the sector average, NextEra still benefits from the predictability of energy demand. For instance, its regulated utilities (i.e., those not powered by renewable energy) require approval from state utility commissions before price hikes can be passed along to households. This might sound like an inconvenience, but it's actually great news. It means NextEra won't be exposed to potentially volatile wholesale pricing.\nVisa\nWhen the next stock market crash arrives, payment processing kingpinVisa(NYSE:V)is a winning company to confidently buy hand over fist. It's also another brand-name company thatcan still make its shareholders a fortune.\nBuying into the Visa growth story is a simple numbers game. Visa grows its revenue and profits when consumers and businesses are spending more. This happens when the U.S. and global economy are expanding. Although contractions and recessions are an inevitable part of the economic cycle, they tend to be short-lived. Meanwhile, periods of economic expansion are almost always measured in years. Buying into Visa during these short-lived crashes or corrections should allow long-term investors to be handsomely rewarded by this numbers game.\nThe other interesting thing about Visa is thatit's shunned becoming a lender. You'd think that Visa could generate big bucks from interest income and fees by lending during these long-lived periods of expansion. But lending would also expose Visa to the credit delinquencies that arise during recessions. Operating solely as a payment processor means not having to set aside cash to cover delinquencies. It's why Visa rebounds so much faster than most financial stocks following a recession.\nAmazon\nLastly (andwho couldn't see this coming?), investors should take any discount they can get during a crash on e-commerce behemothAmazon(NASDAQ:AMZN).\nAmazon's online marketplace has proved virtually unstoppable for well over a decade. An April 2021 report from eMarketer pegged the company's share of U.S. online sales at 40.4%. That more than quintuples its next-closest competitor and effectively solidifies Amazon as the go-to source for online shopping in the U.S.\nWhat about those pesky low retail margins, you ask? Amazon has signed up more than 200 million people globally to a Prime membership. The fees collected from Prime members help to offset some of the company's retail-based margin weakness. Prime members are extremely loyal to the Amazon ecosystem and spend far more than non-members, too.\nBut it's Amazon's cloud infrastructure segmentthat's the superstar. Amazon Web Services (AWS) brings in around one-eighth of the company's total sales but accounts for well over half its operating income. Since cloud margins are superior to retail and advertising margins, AWS is the company's key to explosive cash flow growth this decade.","news_type":1},"isVote":1,"tweetType":1,"viewCount":384,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185502638,"gmtCreate":1623658135724,"gmtModify":1704207966754,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Naked gogogo","listText":"Naked gogogo","text":"Naked gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/185502638","repostId":"1149061517","repostType":2,"repost":{"id":"1149061517","kind":"news","pubTimestamp":1623649290,"share":"https://ttm.financial/m/news/1149061517?lang=&edition=fundamental","pubTime":"2021-06-14 13:41","market":"us","language":"en","title":"7 Penny Stocks To Watch Before They Pop Due to Reddit Users","url":"https://stock-news.laohu8.com/highlight/detail?id=1149061517","media":"InvestorPlace","summary":"Reddit users really like these small-cap stocks\nSource: Shutterstock\n“Meme stock mania” shows no sig","content":"<p>Reddit users really like these small-cap stocks</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c7f158419d387ff2329a9c07f643bde9\" tg-width=\"1024\" tg-height=\"576\"><span>Source: Shutterstock</span></p>\n<p>“Meme stock mania” shows no signs of slowing down. The capacity of short-sellers to endure pain is being examined quite severely by day traders driving up the share prices of meme stocks like&nbsp;<b>AMC</b>(NYSE:<b><u>AMC</u></b>) and&nbsp;<b>GME</b>(NYSE:<b><u>GME</u></b>). However, although these two stocks are trading places for the most popular Reddit stock out there, there are also plenty of penny stocks making waves on subreddits.</p>\n<p>Now you may be thinking if penny stocks are worth the trouble. A penny stock refers to a small company’s stock that trades for less than $5 per share.</p>\n<p>They are not at the top of the list for value investors. Many of the penny stocks are traded over the counter. Thus, the liquidity of the stocks is low.</p>\n<p>In turn, due to the low liquidity, an investor might not be able to cash out at the right time. Furthermore, the low liquidity results in low trading volumes. Even small transactions can have a massive impact on the price of these stocks.</p>\n<p>Still, you will be amazed to find out how many amazing stocks are on this list. None of these companies is an&nbsp;<b>Amazon</b>(NASDAQ:<b><u>AMZN</u></b>) or a&nbsp;<b>Tesla</b>(NASDAQ:<b><u>TSLA</u></b>).</p>\n<p>However, they are interesting performers that have caught the attention of Reddit users, who have become one of<i>the</i>most potent forces on Wall Street recently.</p>\n<p>So, without further ado, here are seven names that are making a major impact on the message boards recently.</p>\n<ul>\n <li><b>Zomedica</b>&nbsp;(NYSEAMERICAN:<b><u>ZOM</u></b>)</li>\n <li><b>Ideanomics</b>&nbsp;(NASDAQ:<b><u>IDEX</u></b>)</li>\n <li><b>Genius Brands</b>&nbsp;(NASDAQ:<b><u>GNUS</u></b>)</li>\n <li><b>Naked Brand</b>&nbsp;(NASDAQ:<b><u>NAKD</u></b>)</li>\n <li><b>Globalstar</b>&nbsp;(NYSEAMERICAN:<b><u>GSAT</u></b>)</li>\n <li><b>Nokia</b>&nbsp;(NYSE:<b><u>NOK</u></b>)</li>\n <li><b>Applied Genetic Technologies</b>&nbsp;(NASDAQ:<b><u>AGTC</u></b>)</li>\n</ul>\n<p>Now, let’s dive in and take a closer look at each one.</p>\n<p><b>Zomedica (ZOM)</b></p>\n<p>Zomedica is a very interesting company.</p>\n<p>A development stage veterinary diagnostic and pharmaceutical company, it is known for its Truforma platform, a machine allowing veterinarians to conduct in-office diagnoses for common diseases affecting canine and feline companions. As a result of the machine, medical professionals can charge higher fees in quick time, increasing margins and reducing costs.</p>\n<p>The company has made only&nbsp;one sale; to Jason Berg, founder, and president of Guardian Veterinary Specialists, a 29,000-square-foot hospital in Brewster, New York.</p>\n<p>Reddit momentum can only help so much. To that end, it has&nbsp;inked a deal with Miller Veterinary Supply, one of America’s oldest wholesale distributors of pet supplies to veterinarians, to market Truforma.</p>\n<p>At the end of 2020, ZOM stock traded for around 23 cents per share. It went as high as $2.91 per share but is now trading under a buck. However, if last week is any indication, you should not treat this stock lightly.</p>\n<p><b>Ideanomics (IDEX)</b></p>\n<p>Considering the popularity of electric vehicle (EV) stocks from mid-2020 onwards, it is not surprising Ideanomics has made its way onto this list of penny stocks.</p>\n<p>Analyzing the company is a tough task. Professional wrestling scion Shane McMahon founded Ideanomics as a financial technology company in 2004. At that time, it was known as&nbsp;<b>China Broadband</b>. A lot of water has passed under the bridge since then and IDEX has gone through several iterations, pivoting in and out of high growth industries at a rapid pace. This has earned the company an unenviable position.</p>\n<p>Ideanomics operates two main divisions, Mobile Energy Global and Ideanomics Capital. The former helps customers get access to commercial electric vehicles, and the other offers fintech products.</p>\n<p>Again, it’s important to highlight Ideanomics is not a fundamentally sound company. However, considering the areas in which it invests, Reddit users will not lose interest in this one anytime soon.</p>\n<p><b>Genius Brands (GNUS)</b></p>\n<p>CEO Andy Heyward believes Genius Brands can become the&nbsp;<b>Netflix</b>&nbsp;(NASDAQ:<b>NFLX</b>) of children’s TV. That is an ambitious claim. However, if any company can pull it off, it stands to make a substantial amount of money.</p>\n<p>For now, Genius Brands does not have the numbers. What it does have our partnerships and licensing agreements with prominent brand names like Stan Lee, Arnold Schwarzenegger, to name a few. In fact, Schwarzenegger ha&nbsp;sinked an agreement&nbsp;to be a “significant investor,” in the kid’s media company.</p>\n<p>The company has made it a habit of sorts to issue fluff press releases that inevitably leads to a bump in the share price. It’s a classic case of “Sell the Sizzle, Not the Steak.” But in the long run, we need to see some traction on the bottom line.</p>\n<p><b>Naked Brand (NAKD)</b></p>\n<p>Reddit has acted like Santa Claus for a number of companies. However, there are few who will be as thankful as Naked Brand. The New Zealand-based company owes its resurgence largely to the r/WallStreetBets subreddit forum.</p>\n<p>At this point, I was fully expecting the company to desist, but in a show of power, the retail investors have given this intimate apparel retailer a new lease on life. Now, NAKD is back in full force and has put into motion a plan to&nbsp;transform itself&nbsp;into a digital enterprise instead of a brick-and-mortar business in Australia and New Zealand.</p>\n<p>Considering Reddit loved this penny stock even before this initiative, I can only imagine how high the stock can go now that there is a semblance of a story to back their ambitions.</p>\n<p><b>Globalstar (GSAT)</b></p>\n<p>You might have not heard of Globalstar but it’s a pretty solid tech penny stock. It offers two-way voice and data devices such as mobile voice and data satellite communications products.</p>\n<p>There are several names on a typical list of penny stocks that do not offer much of a story. However, that is not the case with Globalstar, it provides products and services that we use in our daily lives such as personal tracking, emergency location, and messaging solutions.</p>\n<p>Even without the Reddit-induced price action, this is a great company to have in your portfolio.</p>\n<p><b>Nokia (NOK)</b></p>\n<p>Many thought the Nokia story was over after it lost its epic smartphone battle with&nbsp;<b>Apple</b>(NASDAQ:<b><u>AAPL</u></b>). On the contrary, the Finnish multinational telecommunications company has not transformed itself into a 5G giant.</p>\n<p>In the last decade, Nokia has had several ups and downs. New CEO Pekka Lundmark has said that he wants to work against “complacency and accepting the status quo.” Those are bold words and harken back to the unfortunate circumstances that the multinational had to face as a result of its smartphone business debacle.</p>\n<p>However, investors can rest easy this time around. The company is aggressively buying the 5G spectrum, capital expenditures are healthy and its quarterly earnings are also moving in the right direction.</p>\n<p>Considering all of this, NOK stock becomes one of the safest investments out there.</p>\n<p><b>Applied Genetic Technologies (AGTC)</b></p>\n<p>Applied Genetic Technologies is a biotechnology company that utilizes a&nbsp;proprietary gene therapy platform&nbsp;to produce genetic therapies for patients. It was founded in 1999 and has meandered along since then.</p>\n<p>However, Redditors took an interest in the company recently and pushed up the share price to $9.67 a pop. As I write this, the stock is trading under five bucks again, highlighting the perils of investing in Reddit stocks.</p>\n<p>On a more positive note, the company recently&nbsp;announced additional data&nbsp;from its ongoing X-linked retinitis pigmentosa (XLRP) gene therapy Phase 1/2 trial. The data was positive, indicating an improved, durable response in retinal sensitivity.</p>\n<p>Like most Reddit penny stocks, AGTC is highly sensitive to news releases. So, you need to keep an eye on that section if you want to day trade this one.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Penny Stocks To Watch Before They Pop Due to Reddit Users</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Penny Stocks To Watch Before They Pop Due to Reddit Users\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 13:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/7-reddit-penny-stocks-to-watch-before-they-pop-zom-idex-gnus-nakd-gsat-nok-agtc/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Reddit users really like these small-cap stocks\nSource: Shutterstock\n“Meme stock mania” shows no signs of slowing down. The capacity of short-sellers to endure pain is being examined quite severely by...</p>\n\n<a href=\"https://investorplace.com/2021/06/7-reddit-penny-stocks-to-watch-before-they-pop-zom-idex-gnus-nakd-gsat-nok-agtc/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IDEX":"优点互动","GSAT":"全球星","AGTC":"Applied Genetic Technologies Corporation","ZOM":"Zomedica Pharmaceuticals Corp.","NOK":"诺基亚"},"source_url":"https://investorplace.com/2021/06/7-reddit-penny-stocks-to-watch-before-they-pop-zom-idex-gnus-nakd-gsat-nok-agtc/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149061517","content_text":"Reddit users really like these small-cap stocks\nSource: Shutterstock\n“Meme stock mania” shows no signs of slowing down. The capacity of short-sellers to endure pain is being examined quite severely by day traders driving up the share prices of meme stocks like AMC(NYSE:AMC) and GME(NYSE:GME). However, although these two stocks are trading places for the most popular Reddit stock out there, there are also plenty of penny stocks making waves on subreddits.\nNow you may be thinking if penny stocks are worth the trouble. A penny stock refers to a small company’s stock that trades for less than $5 per share.\nThey are not at the top of the list for value investors. Many of the penny stocks are traded over the counter. Thus, the liquidity of the stocks is low.\nIn turn, due to the low liquidity, an investor might not be able to cash out at the right time. Furthermore, the low liquidity results in low trading volumes. Even small transactions can have a massive impact on the price of these stocks.\nStill, you will be amazed to find out how many amazing stocks are on this list. None of these companies is an Amazon(NASDAQ:AMZN) or a Tesla(NASDAQ:TSLA).\nHowever, they are interesting performers that have caught the attention of Reddit users, who have become one ofthemost potent forces on Wall Street recently.\nSo, without further ado, here are seven names that are making a major impact on the message boards recently.\n\nZomedica (NYSEAMERICAN:ZOM)\nIdeanomics (NASDAQ:IDEX)\nGenius Brands (NASDAQ:GNUS)\nNaked Brand (NASDAQ:NAKD)\nGlobalstar (NYSEAMERICAN:GSAT)\nNokia (NYSE:NOK)\nApplied Genetic Technologies (NASDAQ:AGTC)\n\nNow, let’s dive in and take a closer look at each one.\nZomedica (ZOM)\nZomedica is a very interesting company.\nA development stage veterinary diagnostic and pharmaceutical company, it is known for its Truforma platform, a machine allowing veterinarians to conduct in-office diagnoses for common diseases affecting canine and feline companions. As a result of the machine, medical professionals can charge higher fees in quick time, increasing margins and reducing costs.\nThe company has made only one sale; to Jason Berg, founder, and president of Guardian Veterinary Specialists, a 29,000-square-foot hospital in Brewster, New York.\nReddit momentum can only help so much. To that end, it has inked a deal with Miller Veterinary Supply, one of America’s oldest wholesale distributors of pet supplies to veterinarians, to market Truforma.\nAt the end of 2020, ZOM stock traded for around 23 cents per share. It went as high as $2.91 per share but is now trading under a buck. However, if last week is any indication, you should not treat this stock lightly.\nIdeanomics (IDEX)\nConsidering the popularity of electric vehicle (EV) stocks from mid-2020 onwards, it is not surprising Ideanomics has made its way onto this list of penny stocks.\nAnalyzing the company is a tough task. Professional wrestling scion Shane McMahon founded Ideanomics as a financial technology company in 2004. At that time, it was known as China Broadband. A lot of water has passed under the bridge since then and IDEX has gone through several iterations, pivoting in and out of high growth industries at a rapid pace. This has earned the company an unenviable position.\nIdeanomics operates two main divisions, Mobile Energy Global and Ideanomics Capital. The former helps customers get access to commercial electric vehicles, and the other offers fintech products.\nAgain, it’s important to highlight Ideanomics is not a fundamentally sound company. However, considering the areas in which it invests, Reddit users will not lose interest in this one anytime soon.\nGenius Brands (GNUS)\nCEO Andy Heyward believes Genius Brands can become the Netflix (NASDAQ:NFLX) of children’s TV. That is an ambitious claim. However, if any company can pull it off, it stands to make a substantial amount of money.\nFor now, Genius Brands does not have the numbers. What it does have our partnerships and licensing agreements with prominent brand names like Stan Lee, Arnold Schwarzenegger, to name a few. In fact, Schwarzenegger ha sinked an agreement to be a “significant investor,” in the kid’s media company.\nThe company has made it a habit of sorts to issue fluff press releases that inevitably leads to a bump in the share price. It’s a classic case of “Sell the Sizzle, Not the Steak.” But in the long run, we need to see some traction on the bottom line.\nNaked Brand (NAKD)\nReddit has acted like Santa Claus for a number of companies. However, there are few who will be as thankful as Naked Brand. The New Zealand-based company owes its resurgence largely to the r/WallStreetBets subreddit forum.\nAt this point, I was fully expecting the company to desist, but in a show of power, the retail investors have given this intimate apparel retailer a new lease on life. Now, NAKD is back in full force and has put into motion a plan to transform itself into a digital enterprise instead of a brick-and-mortar business in Australia and New Zealand.\nConsidering Reddit loved this penny stock even before this initiative, I can only imagine how high the stock can go now that there is a semblance of a story to back their ambitions.\nGlobalstar (GSAT)\nYou might have not heard of Globalstar but it’s a pretty solid tech penny stock. It offers two-way voice and data devices such as mobile voice and data satellite communications products.\nThere are several names on a typical list of penny stocks that do not offer much of a story. However, that is not the case with Globalstar, it provides products and services that we use in our daily lives such as personal tracking, emergency location, and messaging solutions.\nEven without the Reddit-induced price action, this is a great company to have in your portfolio.\nNokia (NOK)\nMany thought the Nokia story was over after it lost its epic smartphone battle with Apple(NASDAQ:AAPL). On the contrary, the Finnish multinational telecommunications company has not transformed itself into a 5G giant.\nIn the last decade, Nokia has had several ups and downs. New CEO Pekka Lundmark has said that he wants to work against “complacency and accepting the status quo.” Those are bold words and harken back to the unfortunate circumstances that the multinational had to face as a result of its smartphone business debacle.\nHowever, investors can rest easy this time around. The company is aggressively buying the 5G spectrum, capital expenditures are healthy and its quarterly earnings are also moving in the right direction.\nConsidering all of this, NOK stock becomes one of the safest investments out there.\nApplied Genetic Technologies (AGTC)\nApplied Genetic Technologies is a biotechnology company that utilizes a proprietary gene therapy platform to produce genetic therapies for patients. It was founded in 1999 and has meandered along since then.\nHowever, Redditors took an interest in the company recently and pushed up the share price to $9.67 a pop. As I write this, the stock is trading under five bucks again, highlighting the perils of investing in Reddit stocks.\nOn a more positive note, the company recently announced additional data from its ongoing X-linked retinitis pigmentosa (XLRP) gene therapy Phase 1/2 trial. The data was positive, indicating an improved, durable response in retinal sensitivity.\nLike most Reddit penny stocks, AGTC is highly sensitive to news releases. So, you need to keep an eye on that section if you want to day trade this one.","news_type":1},"isVote":1,"tweetType":1,"viewCount":40,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109704551,"gmtCreate":1619717396173,"gmtModify":1704271330197,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Time to fly high, soar away!! ??","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Time to fly high, soar away!! ??","text":"$Histogenics(OCGN)$Time to fly high, soar away!! ??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109704551","isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374554146,"gmtCreate":1619466288385,"gmtModify":1704724291910,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Awaiting the FDA approval~","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Awaiting the FDA approval~","text":"$Histogenics(OCGN)$Awaiting the FDA approval~","images":[{"img":"https://static.tigerbbs.com/366c085435b4a741f4b4bc05bab87afb","width":"750","height":"1224"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/374554146","isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":191974032,"gmtCreate":1620839039326,"gmtModify":1704349217893,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IPW\">$iPower Inc.(IPW)$</a>??????","listText":"<a href=\"https://laohu8.com/S/IPW\">$iPower Inc.(IPW)$</a>??????","text":"$iPower Inc.(IPW)$??????","images":[{"img":"https://static.tigerbbs.com/082d817e92da6e685928e11314c2e7cf","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/191974032","isVote":1,"tweetType":1,"viewCount":118,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":104441415,"gmtCreate":1620408256537,"gmtModify":1704343357559,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>Hodl only, only next week can see abit more of greens~","listText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>Hodl only, only next week can see abit more of greens~","text":"$Microvision(MVIS)$Hodl only, only next week can see abit more of greens~","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/104441415","isVote":1,"tweetType":1,"viewCount":373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":154946922,"gmtCreate":1625473168066,"gmtModify":1703742360407,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Time to soar!","listText":"Time to soar!","text":"Time to soar!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/154946922","repostId":"2148801599","repostType":2,"repost":{"id":"2148801599","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625576711,"share":"https://ttm.financial/m/news/2148801599?lang=&edition=fundamental","pubTime":"2021-07-06 21:05","market":"us","language":"en","title":"Ocugen says Indian partner's vaccine 93.4% effective against severe COVID-19","url":"https://stock-news.laohu8.com/highlight/detail?id=2148801599","media":"Reuters","summary":"July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's Indian partner, Bharat Biotech, ha","content":"<p>July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's Indian partner, Bharat Biotech, has been found to be 93.4% effective against severe cases of COVID-19 in a late-stage trial, the U.S. drug developer said on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen says Indian partner's vaccine 93.4% effective against severe COVID-19</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen says Indian partner's vaccine 93.4% effective against severe COVID-19\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-06 21:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's Indian partner, Bharat Biotech, has been found to be 93.4% effective against severe cases of COVID-19 in a late-stage trial, the U.S. drug developer said on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2148801599","content_text":"July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's Indian partner, Bharat Biotech, has been found to be 93.4% effective against severe cases of COVID-19 in a late-stage trial, the U.S. drug developer said on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":132114117,"gmtCreate":1622075651639,"gmtModify":1704178897919,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"May it be approved soon then~ the discussion has been way too long.. already no joy upon the news, only the actual graph can excite","listText":"May it be approved soon then~ the discussion has been way too long.. already no joy upon the news, only the actual graph can excite","text":"May it be approved soon then~ the discussion has been way too long.. already no joy upon the news, only the actual graph can excite","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/132114117","repostId":"2138144615","repostType":2,"repost":{"id":"2138144615","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1622075143,"share":"https://ttm.financial/m/news/2138144615?lang=&edition=fundamental","pubTime":"2021-05-27 08:25","market":"us","language":"en","title":"BRIEF-Ocugen Says On Track To Submit EUA Application To U.S. FDA For Its COVID-19 Vaccine Candidate, Covaxin","url":"https://stock-news.laohu8.com/highlight/detail?id=2138144615","media":"Reuters","summary":"May 26 (Reuters) - Ocugen Inc   :   * OCUGEN ON TRACK TO SUBMIT EMERGENCY USE AUTHORIZATION APPLICAT","content":"<html><body><p>May 26 (Reuters) - Ocugen Inc   :</p><p>   * OCUGEN ON TRACK TO SUBMIT EMERGENCY USE AUTHORIZATION APPLICATION TO U.S. FDA FOR ITS COVID-19 VACCINE CANDIDATE, COVAXIN</p><p>   * ACTIVE DISCUSSIONS WITH FDA RELATED TO COVAXIN INITIATED LATE LAST YEAR</p><p>   * MASTER FILE SUBMITTED TO FDA ON MARCH 26, 2021; AWAITING <a href=\"https://laohu8.com/S/FDBK.UK\">FEEDBACK</a> FROM FDA</p><p>   * CONFIRMED ITS PLAN TO SUBMIT ITS EUA APPLICATION FOR COVAXIN TO U.S. FOOD &amp; DRUG ADMINISTRATION (FDA) IN JUNE</p><p>   * BELIEVE THAT FDA'S NEW GUIDANCE CONFIRMS THAT OCUGEN CONTINUES TO MEET ALL CRITERIA FOR SUBMISSION OF AN EUA</p><p>   * ONCE EUA APPLICATION HAS BEEN SUBMITTED, OCUGEN INTENDS TO COMMENCE PRE-BIOLOGICS LICENSE APPLICATION DISCUSSIONS WITH FDA</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Ocugen Says On Track To Submit EUA Application To U.S. FDA For Its COVID-19 Vaccine Candidate, Covaxin</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Ocugen Says On Track To Submit EUA Application To U.S. FDA For Its COVID-19 Vaccine Candidate, Covaxin\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-05-27 08:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>May 26 (Reuters) - Ocugen Inc   :</p><p>   * OCUGEN ON TRACK TO SUBMIT EMERGENCY USE AUTHORIZATION APPLICATION TO U.S. FDA FOR ITS COVID-19 VACCINE CANDIDATE, COVAXIN</p><p>   * ACTIVE DISCUSSIONS WITH FDA RELATED TO COVAXIN INITIATED LATE LAST YEAR</p><p>   * MASTER FILE SUBMITTED TO FDA ON MARCH 26, 2021; AWAITING <a href=\"https://laohu8.com/S/FDBK.UK\">FEEDBACK</a> FROM FDA</p><p>   * CONFIRMED ITS PLAN TO SUBMIT ITS EUA APPLICATION FOR COVAXIN TO U.S. FOOD &amp; DRUG ADMINISTRATION (FDA) IN JUNE</p><p>   * BELIEVE THAT FDA'S NEW GUIDANCE CONFIRMS THAT OCUGEN CONTINUES TO MEET ALL CRITERIA FOR SUBMISSION OF AN EUA</p><p>   * ONCE EUA APPLICATION HAS BEEN SUBMITTED, OCUGEN INTENDS TO COMMENCE PRE-BIOLOGICS LICENSE APPLICATION DISCUSSIONS WITH FDA</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2138144615","content_text":"May 26 (Reuters) - Ocugen Inc   :   * OCUGEN ON TRACK TO SUBMIT EMERGENCY USE AUTHORIZATION APPLICATION TO U.S. FDA FOR ITS COVID-19 VACCINE CANDIDATE, COVAXIN   * ACTIVE DISCUSSIONS WITH FDA RELATED TO COVAXIN INITIATED LATE LAST YEAR   * MASTER FILE SUBMITTED TO FDA ON MARCH 26, 2021; AWAITING FEEDBACK FROM FDA   * CONFIRMED ITS PLAN TO SUBMIT ITS EUA APPLICATION FOR COVAXIN TO U.S. FOOD & DRUG ADMINISTRATION (FDA) IN JUNE   * BELIEVE THAT FDA'S NEW GUIDANCE CONFIRMS THAT OCUGEN CONTINUES TO MEET ALL CRITERIA FOR SUBMISSION OF AN EUA   * ONCE EUA APPLICATION HAS BEEN SUBMITTED, OCUGEN INTENDS TO COMMENCE PRE-BIOLOGICS LICENSE APPLICATION DISCUSSIONS WITH FDASource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":139,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":198352703,"gmtCreate":1620934658202,"gmtModify":1704350693558,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>18-20% surge can’t be all we got right…. ☝?☝?","listText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>18-20% surge can’t be all we got right…. ☝?☝?","text":"$Naked Brand(NAKD)$18-20% surge can’t be all we got right…. ☝?☝?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/198352703","isVote":1,"tweetType":1,"viewCount":114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":198353863,"gmtCreate":1620932289152,"gmtModify":1704350687575,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>+8% to +10% now, what are the chances post market +50%? Hmm ?&nbsp;","listText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>+8% to +10% now, what are the chances post market +50%? Hmm ?&nbsp;","text":"$Naked Brand(NAKD)$+8% to +10% now, what are the chances post market +50%? Hmm ?","images":[{"img":"https://static.tigerbbs.com/232e738544f046976097799c1859a843","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/198353863","isVote":1,"tweetType":1,"viewCount":112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":199937181,"gmtCreate":1620661395243,"gmtModify":1704346400639,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RVPH\">$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$</a>Today financial report, hope all is good ?? it has been WAYYYYY too long since there is any much movement from this!","listText":"<a href=\"https://laohu8.com/S/RVPH\">$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$</a>Today financial report, hope all is good ?? it has been WAYYYYY too long since there is any much movement from this!","text":"$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$Today financial report, hope all is good ?? it has been WAYYYYY too long since there is any much movement from this!","images":[{"img":"https://static.tigerbbs.com/9dd3683913de87a812e74b9342ebec2b","width":"750","height":"1224"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/199937181","isVote":1,"tweetType":1,"viewCount":117,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":100437798,"gmtCreate":1619627994214,"gmtModify":1704727105116,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>It’s about time right?","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>It’s about time right?","text":"$Histogenics(OCGN)$It’s about time right?","images":[{"img":"https://static.tigerbbs.com/ce069da250fec60bf526a73af59f6c4e","width":"750","height":"1224"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/100437798","isVote":1,"tweetType":1,"viewCount":334,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":100434843,"gmtCreate":1619627884282,"gmtModify":1704727103340,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RVPH\">$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$</a>Really need to hold till clinical trial phase 3 to see it ? again","listText":"<a href=\"https://laohu8.com/S/RVPH\">$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$</a>Really need to hold till clinical trial phase 3 to see it ? again","text":"$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$Really need to hold till clinical trial phase 3 to see it ? again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/100434843","isVote":1,"tweetType":1,"viewCount":106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374554942,"gmtCreate":1619466169086,"gmtModify":1704724291583,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Time to soar ?? 14-15 tomorrow will be good ????","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Time to soar ?? 14-15 tomorrow will be good ????","text":"$Histogenics(OCGN)$Time to soar ?? 14-15 tomorrow will be good ????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/374554942","isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":154941707,"gmtCreate":1625473069409,"gmtModify":1703742357615,"author":{"id":"3582000739695630","authorId":"3582000739695630","name":"Raymond1109","avatar":"https://static.tigerbbs.com/6bcd5134cf658a22c90379139fc8ea6f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582000739695630","authorIdStr":"3582000739695630"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/154941707","repostId":"155231719","repostType":1,"repost":{"id":155231719,"gmtCreate":1625438214331,"gmtModify":1703741555205,"author":{"id":"3564546889826365","authorId":"3564546889826365","name":"koonkoon","avatar":"https://static.tigerbbs.com/5dcc75085d1205dc8567a05395bac661","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3564546889826365","authorIdStr":"3564546889826365"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCG</a>n)good news","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCG</a>n)good news","text":"$Histogenics(OCGn)good news","images":[{"img":"https://static.tigerbbs.com/289870db1bfd26ce1e7e3a3fe788f25c","width":"1080","height":"975"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/155231719","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}